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Abstract 
Recently there is a growing interest in cancer treatment through the use of natural 
compounds. In particular, phenolic compounds and monoterpenes found in fruits and 
vegetables are very attractive in the prevention and chemotherapy of various types of 
cancer. However, many promising compounds previously tested in in vitro cell models fail 
to demonstrate activity when evaluated in vivo. Therefore, there is an emerging need to 
develop more robust and reliable cellular models for pre-clinical evaluation of new 
chemotherapeutic agents. 
The main goal of this thesis was the evaluation of the chemotherapeutic potential of 
natural extracts, rich in bioactive compounds, using 3D models of colon cancer. For this 
purpose, a 3D model of human colorectal cancer cell line HT29 was developed. 
By culturing HT29 cells in a stirred culture system, it was possible to obtain 3D cellular 
spheroids with different size diameter during culture time. It was verified phenotypic 
changes within the spheroid along culture, such as formation of apoptotic core and altered 
expression of stem and epithelial markers in different spheroid areas, which are typical 
features of tumor progression. 
After an initial screening of the antiproliferative potential of 14 natural extracts performed 
in a 2D model of HT29 cells, the most promising samples were selected for further analysis 
in the 3D model. Cherry and orange extracts showed potential anticancer effect in HT29 
aggregates through the inhibition of cell proliferation, induction of apoptosis and cell cycle 
arrest. A decrease on the bioactive effect was verified with the increase of aggregate 
diameter, probably due to limited diffusion. The anticancer activity was correlated with 
the phytochemical composition of natural extracts. For cherry extract, perillyl alcohol was 
the main bioactive compound identified whereas for orange extract, compounds like 
nobiletin, tangeretin and sinensetin were highlighted. 
Results of this thesis demonstrated that natural extracts of cherry and orange contain 
bioactive molecules with promising application on the development of new therapies for 
colon cancer treatment. The use of 3D cell models is a valuable tool for the study and 
evaluation of the effect of new chemotherapeutic compounds. 
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Resumo 
Recentemente tem surgido um interesse crescente no tratamento de cancro através do uso 
de compostos naturais. Nomeadamente, os compostos fenólicos e os monoterpenos, 
presentes em frutas e vegetais, são muito atrativos na prevenção e quimioterapia de 
diversos tipos de cancro. Muitos dos compostos promissores, previamente testados em 
modelos celulares in vitro, apresentam falhas quando avaliados in vivo. Como tal, existe 
uma necessidade emergente de desenvolvimento de novos modelos celulares, mais 
robustos e mais representativos do tecido in vivo, para avaliação pré-clínica de novos 
agentes quimioterapêuticos. 
Neste trabalho pretendeu-se avaliar o potencial quimioterapêutico de extratos naturais, 
ricos em compostos bioativos, usando modelos 3D de cancro do colon. Para tal, foi 
necessário proceder ao desenvolvimento do modelo usando uma linha celular humana de 
cancro do colon (HT29). 
Foi possível obter, com reprodutibilidade, um modelo celular 3D (agregados) de cancro do 
colon usando um sistema de cultura agitado, tendo estes apresentado um fenótipo variável 
ao logo do tempo de cultura. Estas alterações, tais como, a formação de um centro 
apoptótico e alterações na expressão de marcadores estaminais e epiteliais, são também 
características da progressão tumoral.  
Após um estudo inicial onde foi avaliada a capacidade antiproliferativa de 14 extratos 
naturais num modelo 2D de células HT29, foram selecionadas as amostras mais 
promissoras para posterior análise no modelo 3D. Os extratos de cereja e laranja 
apresentaram potencial efeito anticancerígeno no novo modelo desenvolvido, através da 
inibição da proliferação celular, da indução da apoptose e paragem do ciclo celular, tendo-
se registado uma diminuição do efeito bioativo com o aumento do agregado. A atividade 
anticancerígena foi correlacionada com a composição fitoquímica dos extratos. Para o 
extrato de cereja foi enfatizada a relevância do álcool perílico e, no caso, do extrato de 
laranja, compostos como a nobiletina, tangeretina e sinensetina foram destacados. 
Os resultados obtidos demonstraram o potencial promissor dos compostos naturais no 
desenvolvimento de novas terapias aplicadas ao tratamento do cancro do colon. O uso de 
modelos celulares em 3D constitui uma boa ferramenta para o estudo e avaliação do efeito 
quimioterapêutico de novos compostos.  
 
 
Palavras-chave: Modelos celulares em 3D; Cancro do colon; Extratos naturais; 
Fitoquímicos; Quimioterapia 
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1 Introduction 
 
1.1 Colon Cancer 
Cancer is the primary cause of death in economically developed countries and the second in 
developing countries, representing around 13% (7.6 million) of total deaths. Most of these 
deaths are due to lung, stomach, liver, colon and breast cancer [1]. 
Particularly, colon cancer is one of the most common and lethal diseases in developed 
countries (Figure 1.1), being the third most common cause of cancer in men and the second 
cause in women worldwide. In Europe, this malignancy kills 230,000 citizens every year and 
it is the second most common malignant tumor. Colon cancer continuous to be one of the 
most incident cancers, however, over the past 10 years, death rates have declined 3% in US 
[2]. 
 
Figure 1.1: World age-standardized mortality rates of colorectal cancer, 2008 data [3]. 
Colon is a muscular tube with about 150 centimeters which absorbs water and salt from the 
lumen. Colon has 4 sections, including ascending, transverse, descending and sigmoid colon. 
The layers of the large intestine are mucosa, submucosa, muscularis and serosa [4]. Human 
colon mucosa is made from a single sheet of columnar epithelial cells, which form 
invaginations into the underlying connective tissue, constituting the basic functional unit of 
the intestine, the crypt. Colon is formed by millions of crypts and evidences document the 
presence of a stem-cell population at the base of the crypt [5]. These stem cells present a 
key role in intestinal regeneration, however, they can acquire mutations that can lead to 
malignancy. Stem cells of colonic crypt present as natural targets of transformation, due to 
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their longevity and self-renewing capacity [6]. Apoptosis is a crucial mechanism to control 
and promote normal crypt homeostasis [7]. 
Colon cancer arises from colon cells and can be designated colorectal cancer, if neoplasms 
are found from caecum to rectum. This abnormal growth of cells caused by several gene 
mutations, result in a dysregulated balance between cell proliferation and death. Ultimately, 
these cells can invade tissues and metastasize to distant sites which is typical from 
malignant cancer cells [8]. 
The development of colon cancer can occur with different proliferation rates, but, in 
general, it is a slow process that evolves several years. Most cases begin as polyps, which are 
benign tumors made from the excessive proliferation of the inner lining cells. Some polyps 
remain as non-cancerous tumors (hiperplastic and inflammatory polyps) and others can 
evolve into a pre-malignant type, designated as adenoma or adenomatous polyps. This type 
of polyps originates adenocarcinomas (malignant type), which represents more than 98% 
of total colorectal cancers (Figure 1.2). These tumors arise from glandular epithelial cells of 
mucosa, which produces mucus that lubricates the lumen of the large bowel. 
Adenocarcinoma formation process can take 5-10 years to occur and only around 10% of 
adenomas become cancer [9]. There are other types of colon tumors which are less 
prevalent, such as carcinoid and gastrointestinal stromal tumors, lymphomas and sarcomas 
[10] 
 
Figure 1.2: Colorectal adenocarcinoma progression stages. The lower stage indicates a smaller tumor 
with less proliferation and the higher stage represents a bigger tumor with invasion (adapted from 
National Cancer Institute) [11]. 
 
The sporadic type of colon cancer, which is the most common, arises from the accumulation 
of genetic mutations. Carcinogenesis is a long and multistep process, which comprises 
irregular genetic modifications. Fearon and Vogelstein (1990) have proposed a genetic 
model for colon carcinogenesis creating a correlation between genetic events and tissue 
morphology [12]. In order to start the malignant formation it is required the mutation of a 
cascade of genes. This cascade starts when Adenomatous Polyposis Coli gene (APC), a tumor 
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suppressor gene, becomes inactivated by mutation. Then, it progresses with more genetic 
mutations in other tumor-suppressing genes such as K-ras (Figure 1.3). This events, 
combined with DNA modulation by methylation, leads to the inactivation of repair genes or 
the amplification of oncogenes activation. All these genetic damages are morphologically 
related with the developing process of polpys and adenomas [13]. 
 
Figure 1.3: Multiple step model of sporadic colorectal carcinogenesis and progression (adapted from 
[8]). 
One prominent genetic change occurs in p53, a tumor suppressor gene. The p53 has been 
implicated in 80% of sporadic colon cancer cases. It is the most frequently mutated gene 
found in solid tumors [14]. Other tumor suppressor genes have been reported, such as MCC, 
DCC and DPC-4 [15]. 
 
 
1.1.1 Risk Factors 
As mention above, developed countries appears to have a higher incidence of colon cancer 
and it can be linked with modern diet (high dietary intake of fat, refined carbohydrates, 
animal protein and low intake of fiber) and lifestyle, combined with lack of physical activity 
[16]. The majority of colon cancer cases are sporadic, which mean that they are not related 
to genetic inheritance or family history. The major risk factor is age and, in fact, 90% of 
these tumors are diagnosed after the age of 50 years. This profile may be due to a lifetime of 
biochemical injuries resulting from the risk factors previously described. Other risk factors 
involved in sporadic type includes: prior personal colon cancer history, inflammatory bowel 
disease, radiation exposition and acromegaly [17]. 
Another strong factor for the development of colorectal cancer is the genetic predisposition. 
There are two known genetically inherited syndromes: familial adenomatous polyposis 
(FAP) and hereditary non-polyposis colon cancer (HNPCC). These are the most common 
familial colon cancer syndromes, but together they account for only about 5% of colorectal 
cancer cases [18]. HNPCC can be caused by a mutation in one of several DNA mismatch 
repair (MMR) genes. MMR system prevents incorrect base pairing and when they are 
inactivated there is an accumulation of spontaneous mutations in DNA microsatellites [17]. 
FAP is the most characterized familial syndrome and it is caused by the mutation of the APC 
gene [17]. 
 
 
APC K-ras DCC/DPC4 p53
Normal 
Epithelium
Early 
Adenoma
Intermediate 
Adenoma
Late
Adenoma
Colon 
Adenocarcinoma
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1.1.2 Metastization 
Metastasis is the dissemination of malignant cells from the primary tumor to a distant organ 
and it constitutes the leading cause of death for cancer patients. It is a complex molecular 
mechanism that includes cancer cell migration and invasion into adjacent tissues and 
intravasation (cells enter in blood space to travel to distant organs) into blood/ lymphatic 
vessels [19]. Despite the clinical importance, the biological process of metastasis remains 
poorly understood. However, several studies have shown that tumor cells penetrate 
adjacent tissues by different ways. They can disseminate as individual cells, such as 
leukemia, lymphomas and most solid stromal tumors, or they can expand in solid cell 
strands, sheets files or clusters, commonly observed in epithelial tumors. Usually, the lower 
differentiation stages are more likely to spread by  individual cells [20].  
Metastasis formation involves a multiple step process. First, there is the development of a 
blood supply that can support the metabolic demands, a process called angiogenesis. These 
new blood vessels provide a route by which the malignant cells can escape from the primary 
tumor and enter into the blood stream. Cancer cells can also get access into circulatory 
system indirectly, through the lymphatic system. Once in the circulation, they extravasate to 
the surrounding tissue, starting a new proliferation process (Figure 1.4) [21].  During the 
invasion process, cancer cells penetrate the basement membrane and interstitial stroma 
through proteolysis of extracellular matrix (ECM). Metalloproteinases (MMPs) play a crucial 
role for this EMC proteolysis [22]. 
 
Figure 1.4: Metastatic process schematization. (a) in situ cancer. (b) invasion begins with changes in 
cell-cell and cell-EMC adherence, destruction of stroma and motility. The cells can migrate (c) via 
lymphatic or (d) directly in the blood circulation. (e) survival, arrest of metastatic cancer cells and 
extravasation of circulatory system. (f) colonization of distant organs which might remain inactive 
for years, occulting micrometastases and (g) growing of secondary tumor and angiogenesis [23]. 
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Epithelial-mesenchymal transition (EMT) plays an important role in the invasive cascade 
because it marks the transition from a collective to a single-cell migration mechanism. The 
development of metastasis requires the movement of cancer cells, driving the progression 
of carcinomas to an invasive and metastatic phonotype.  In general, EMT process occurs 
during embryonic development in order to escape from structural constraints imposed by 
tissue architecture, adopting a more flexible cell movement capacity. Briefly, during EMT, 
epithelial cancer cells lose their polarity and some cell-cell and cell-ECM adhesion systems, 
resulting in reduced intercellular interactions and increased migratory character as 
mesenchymal cells. In the metastatic process, EMT enables cancer cells to disseminate from 
a primary tumor and promotes their self-renewal, required for metastases progression. The 
loss of expression of structural epithelial proteins (E-cadherin, plakoglobin and 
cytokeratins) was verified, when epithelial cells become invasive. E-cadherin is an adhesion 
molecule essential for the maintenance of adherents junctions, thus, the loss of their 
expression is a hallmark characteristic of EMT [24]. These phenotypic alterations, in 
general, are accompanied by the expression of vimentin and other mesenchymal 
characteristic proteins [25]. In Table 1.1 are summarize the main phenotypic alterations 
associated with EMT in colon carcinoma. 
 
Table 1.1: Phenotypic alterations associated with EMT in colorectal carcinoma [25]. 
 
The role of β-catenin in E-cadherin-mediated cell-cell adhesion is essential for the study of 
the molecular basis of EMT and malignant cancer development. In colon epithelia, β-catenin 
links E-cadherin to the actin in cytoskeleton. The dismantling of cell-cell adhesion (loss of E-
cadherin) during EMT releases β-catenin which displays an important role in the regulation 
of EMT. Indeed, it is usual to find β-catenin accumulation in the cell nucleus of the invasive 
carcinoma cells, instead of being located in the plasmatic membrane [25].  
Once cancer cells have been established in the tissue, the new stroma environment lacks 
signaling to undergo an EMT. This allows cancer cells to revert the prior process and occurs 
 Epithelial  Mesenchymal 
Polarization 
Polarized with differences between 
apical and basal membrane 
constituents 
 
No apical-basal membrane 
polarity, elongated morphology 
Cell-cell 
contacts 
Strong cell-cell junctions as tight 
and adherent and desmosomes 
 
Weak cell-cell contacts 
discernible 
Structural 
proteins 
E-cadherin, cytokeratins 
 
 
 
Vimentin 
Extracellular 
environment 
Basement membrane containing 
type IV collagen and laminin 
 
Expression of type I collagen, 
fibronectin and 
metalloproteinases 
Motility Non-motile cells  
Highly motile cells often 
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a mesenchymal-epithelial transition [26]. Thus, EMT process makes possible cancer cell 
dissemination and enables a self-renewal capacity to metastatic cancer cells [27].  
 
 
1.1.3 Chemotherapy 
The success of chemotherapy in the treatment of malignant diseases has been dramatic. In 
the most common carcinomas (breast, colon and lung) the effectiveness of 
chemotherapeutic agents has been disappointing [28]. 
Usually, cancer therapies, including surgery, chemotherapy and radiotherapy, have a limited 
but important role in the overall treatment of most solid tumors. In early-stage disease, low 
risk patients are often cured with surgery alone, but in many other cases a combination of 
treatments is required. The use of combined therapies or agents, which act through 
different molecular mechanisms, has been considered as  a promising strategy [29]. These 
mechanisms are summarized in Figure 1.5. 
 
Figure 1.5: Therapeutic targeting of the Hallmarks of Cancer. Drugs that interfere with each of the  
acquired abilities necessary for tumor growth and progression have been developed and are in 
clinical trials [30]. 
In recent years, it has been achieved great improvements in the knowledge of intracellular 
mechanisms, which are involved in cell cycle deregulation and the response of cancer cells 
to external growth factors. Cancer cells differ from normal cells due to their ability to grow 
and survive. The accumulation of mutations on proto-oncogenes and tumor suppressor 
genes promote cell division and generate insensitivity to growth inhibitory signals. 
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Chemotherapy drugs cause apoptosis by directly interfering with DNA or by targeting the 
key proteins involved in cell division [31]. 
Cell cycle is controlled by several checkpoints. These points are regulated by the transient 
association of cyclin and cyclin-depend kinase in order to determine the progression into 
next stage of division. Cyclins appear to act as oncogenes in some type of cancers. Hence, 
there are multiples aberrant pathways which can be exploited by drug design. In addition, 
different phases of the cell cycle  or different signaling pathways are targeted to achieve 
maximal cell kill and the less likelihood of resistance [31, 32]. 
The most successful drug used in chemotherapy of colon cancer is 5-fluorouracil (5-FU). 
Particularly, this type of cancer is usually treated with a combinatory therapy with other 
drugs. It has been reported various mechanisms of action, including inhibition of 
thymidylate synthase and incorporation into RNA and DNA. Pyrimidine de novo synthesis is 
impossible without thymidylate synthase activity and their inhibition results in a decrease 
of DNA synthesis and repair [33]. 
In general, standard anticancer drugs show low efficacy in providing long term resolutions 
in epithelial tumors. Recently, this limited effectiveness of anticancer therapies has been 
attributed to the existence of cancer stem cells (CSCs), which confers a highly drug resistant 
phenotype to the tumor. CSCs are characterized by their unlimited ability to self-renew, to 
be undifferentiated and seed new tumors with the same cellular heterogeneity. In the 
metastasis process, disseminated cancer cells require self-renewal capability, very similar 
to that exhibited by stem cells, in order to generate metastases in distant parts of the body 
[27]. Further, it is believed that common chemotherapy kills most cells in a tumor but leaves 
CSCs behind. It has already been shown that drug transporters protect CSCs from 
chemotherapeutic agents. This drug’s resistance mechanism is due to the expression of high 
levels of specific ATP-binding cassettes (ABC) drug transporters which have roles in the 
transport of drugs across the cells. Other stem cells properties that provide a long lifespan 
include the relative quiescence, an active DNA-repair capacity and resistance to apoptosis 
[34]. 
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1.2 Natural compounds and colon cancer 
Over 200 years ago, Friedrich Sertäurner, a pharmacist´s apprentice, isolated the first 
pharmacologically active pure compound from a plant. This compound was morphine from 
opium, produced by cutting the seed pods of the poppy, Papaver somniferum [35]. After this 
event, it was started a new era where drugs from plants could be purified, studied and 
administered. In 1990 about 80% of drugs were natural products or analogs inspired by 
them, causing a revolution in medicine. However, during the 90’s,  it was observed an 
expansion in the synthetic medicinal chemistry, driving to a decrease of proportion of new 
drugs based on natural products to 50% [36, 37]. Nevertheless, natural products continue 
to provide unique structural diversity in analogy to standard chemistry. Since less than 10% 
of world’s biodiversity has been evaluated for potential biological activity, many useful 
natural compounds await discovery [38]. 
The World Health Organization estimates that 80% of worldwide population chooses 
traditional medicine for primary health care [39]. Essential oils from plants, nutraceutical 
products, dietary supplements, herbal remedies, teas and infusions are the main selected 
products [36]. 
As a source of new pharmaceuticals, natural products and derived molecules play an 
important role due to the great variety of functionally relevant metabolites of microbial and 
plant species. The development of improved products and new drugs can provide to  drug 
development the scientific tools needed to perform a robust study of natural compounds 
and traditional medicines [40]. To be eligible as a medicinal plant or compound, it is 
necessary to take considerations about phytochemical analysis and pharmacological 
screening, which includes studies in vitro and in animal models. It needs further verification 
in order to identify the most bioactive components and their mechanisms of action, activity 
and cytotoxicity profiles. In 2008, over 100 natural products-derived compounds were 
undergoing clinical trials and, at least, 100 products in preclinical development. Most of 
them were derived from plants and microbial sources and these products were 
predominantly being study for the use in cancer or as anti-infectious agents[36, 41].  
In the context of colon cancer, multiple natural products and their bioactive phytochemicals 
have been found to exert anticancer effects by inducing cell-cycle arrest and apoptosis, 
decreasing cell proliferation and angiogenesis while inhibiting cancer cell invasion and 
migration. Besides, phytochemical compounds can also modulate several signals 
transduction and pathways involved in colon cancer development, including COX-2/PGE2 
and Wnt/β-catenin [42]. Various in vitro studies in a wide range of colon cancer cell lines 
have shown the chemopreventive and chemotherapeutic effects of natural products and 
their constituents (Figure 1.6) [43]. In addition, in vivo studies using experimental 
carcinogenesis models have also been reported for the same natural products [44, 45]. 
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Figure 1.6: Different mechanisms of action of natural products in colon cancer prevention and 
therapy (adapted from [43]). 
Several developments in organic chemistry have been inspired by natural products, 
including the advances in methodologies and the possibility for synthesizing analogues of 
the original compound with enhanced pharmacological proprieties [46]. Natural products 
can provide ‘privileged’ structures in terms of their ability to be the basis of new drugs.  
Natural products libraries are basically based on 3 major groups of phytochemical 
compounds, namely alkaloids, phenolics and terpenoids. The application of several 
techniques allows the creation of analogues and derivatives of these phytochemical 
compounds, with the possibility of being patented. Actually, with the development of 
analytical techniques, it has become easy to isolate, purify and determine structures of 
relevant compounds present in natural products [36].  
Phenolic compounds, found in a large variety of plants, have shown to inhibit or attenuate 
the initiation, progression and spread of cancer cells, both in vitro and in animal models in 
vivo. This phytochemicals are secondary metabolites and can be monophenolic (one 
phenolic aromatic ring) or polyphenolic (more than one aromatic ring). Up to now, over 
8000 different phenolics in plants were identified and classified in multiple sub groups of 
compounds (Figure 1.7). Flavonoids are the most abundant and numerous plant phenolics 
and can be found in high concentrations in the leaf epidermis and fruit skins due to their 
important role in pigmentation, UV protection and disease [47].  
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Figure 1.7: Schematic classification of phenolic compounds reported to have health benefits (adapted 
from [47]). 
Phenolic compounds play a significant role in the suppression of tumor initiation, as well as 
in the promotion and progression of cancer. They can act in the regulation of growth 
factors-receptor interactions and in cell signaling cascades, such as kinases and 
transcription factors, which determines cell cycle arrest, cell survival and apoptosis. 
Aberrant growth factor expression results in an uncontrolled cell proliferation. 
Furthermore, phenolic compounds can enhance immune system to recognize and destroy 
cancer cells, inhibit angiogenesis and reduce the metastatic potential. The antiangiogenic 
effect appears to be linked with attenuation of MMPs and inhibition of vascular endothelial 
growth factor (VEGF) [47]. 
Terpenoids or terpenes are the largest group of natural compounds and many of them 
present bioactivity in the treatment of human diseases. Among the terpene-based 
pharmaceuticals already commercialized, it can be found a successful anticancer drug, the 
Taxol®. Besides anticancer properties, terpenes display a wide range of other biological 
activities against inflammation and infectious diseases. They can be structurally classified as 
monoterpenes (C10), sesquiterpenes (C15), diterpenes (C20) and sesterterpenes (C25) [48]. 
Monoterpenes are nonnutritive constituents of the essential oils of citrus fruits, cherry, mint 
and herbs. Antitumor activity of several monoterpenes was extensively reported [49]. 
Limonene, carvone and perillyl alcohol are the most interesting molecules as 
chemopreventive and chemotherapeutic agents against tumor cells. The mechanism of 
action is mainly related with the induction of apoptosis and the interference with key 
regulatory proteins (Figure 1.8) [48, 49]. 
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Figure 1.8: Actions of monoterpenes in cancer prevention and therapy [49]. 
Alkaloids are a diverse group of compounds that contain one or more nitrogen atoms, 
usually, in a heterocyclic ring. They are widely distributed in the plant kingdom, mainly in 
higher plants. Alkaloids are among the most important bioactive components and some of 
them have already been successful in cancer chemotherapy [50]. Vinca alkaloids 
(vinablastine, vincristine and vinerolbine) isolated from Madagascar periwinkle are 
anticancer agents in clinical use [51]. Recently, other anticancer relevant alkaloids have 
been studied, such as berberine, matrine and evodiamine. They act in several cancer 
mechanisms, including apoptosis, cell cycle arrest, angiogenesis, metastasis, and others [50]. 
Despite a period of decrease in their use, there are multiple natural compounds candidates 
for new drugs in current development. Phytochemical compounds provide the core 
scaffolds for future drugs due to an increasing acceptance of public opinion. In the future, 
the continuing development of natural products and chemical libraries based on natural 
products will continue to grow in drug research [36]. 
Several fruits have been reported as strong sources of phytochemical compounds, as 
previously described. The high content in these potential anticancer compounds makes this 
natural extracts as having therapeutic interest. The use of the fruit wastes as a source of 
bioactive compounds might be an approach to recover phenolic compounds and terpenoids. 
Fruits as olives, oranges, plums, peaches and cherries present several anticancer molecules 
that can be selectively extracted in order to obtain an extract with anticancer activity [52-
55]. 
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1.2.1 Olive  
Olive tree (Oleaceae) has a great economic and social role in Mediterranean countries and it 
is one of the most important agricultural activities in this area. Oil and olives are the main 
products of olive-related industry, which generates large volumes of by-products such as 
crude olive cake, vegetation water, twigs and leaves [56, 57]. Olive products have shown 
beneficial effects on human health mostly due to the presence of antioxidants such as 
phenolic compounds, carotenoids and tocopherols that assume an important function in 
disease prevention [58, 59]. Studies demonstrate the presence of anticancer active 
phenolics in olive fruit, including, luteolin, apigenin, oleuropein, rutin and hydroxytyrosol 
(Table 1.2) [60]. The anti-colon cancer activity of olive fruit skin terpenoids-rich extracts 
have been also reported [61]. 
The stone represents 18-22% of total olive weight. It is mainly formed by lignocellulosic 
material with commercial interest for production of solid, liquid or gas biofuel. Despite the 
relevance for the biofuel industry, olive stone is a rich source of valuable components due to 
their chemical and physical properties. Like the olive fruits, the presence of phenolic 
compounds in olive seed is also important. Several anticancer compounds have been 
already identified, including, tyrosol, oleuropeina and their derivatives (Table 1.2) [62]. 
 
Table 1.2: Reported anticancer activity of phenolic compounds from olive. 
Phenolics Mechanism of anticancer activity Cancer model Ref 
Tyrosol ↑ apoptosis 
in vitro 
(cell-based assays) 
[63] 
Hydroxytyrosol G1 arrest, ↑ apoptosis, ↓ ROS 
in vitro 
(cell-based assays) 
[63] 
Oleuropein 
S arrest, ↓cell proliferation, ↓ 
invasion, ↓  migration, angiogenesis 
inhibition 
in vitro 
(cell-based assays) 
in vivo 
(mouse model) 
[64, 65] 
Verbascoside ↓ ROS, ↑ tumor differentiation 
in vitro 
(cell-based assays) 
[66, 67] 
Apigenin 
G2/M arrest, ↓cell proliferation, ↑ 
apoptosis, carcinogens detoxification 
in vitro 
(cell-based assays) 
in vivo 
(mouse model) 
[68-70] 
Luteolin  
↓ ROS, G2/M arrest, ↓cell 
proliferation, ↑ apoptosis, 
angiogenesis inhibition, carcinogens 
detoxification 
in vitro 
(cell-based assays) 
in vivo 
(mouse model) 
[71, 72] 
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1.2.2 Orange 
Citrus fruits have commercial relevance due to their nutritional value and special flavor.  
About 34% of orange production was used for juice production, where a large amount of 
residues is produced, constituted mainly by orange peels [52]. Thus, large amounts of peels 
are produced every year; this residue is the primary waste fraction. 
Sweet orange (Citrus sinensis) peel is an interesting source of phenolic compounds such as 
polymethoxylated flavonoids and terpenoids, mainly limonene and linalool [52]. 
Polymethoxyflavones (PMFs) have been of particular interest because these flavonoids 
display a large spectrum of biological activities, including, anti-inflammatory, anticancer 
(Table 1.3) and antioxidant. These compounds are particularly abundant in sweet orange 
[73-76]. PMFs are lipophilic molecules due to the hydrophobic nature of methoxy groups, in 
comparison to hydroxyl groups, as observed in quercetin, luteolin and narigenin. 
Consequently, PMFs have shown a higher absorbance through the small intestine and are 
easily absorbed into the blood circulation system [52]. All of these beneficial actions suggest 
new value-added uses for these compounds as nutraceuticals, generating considerable 
interest to the citrus industry. 
Tangeretin and nobiletin are among the most effective citrus flavonoids at inhibition of 
human cancer cell proliferation [70]. In addition, in vivo antitumor studies of PMFs reveal 
their safe pharmacological use [73]. 
 
Table 1.3: Reported anticancer activity of orange peel flavonoids. 
Flavonoids Mechanism of anticancer activity Cancer model Ref 
Tangeretin 
G1 arrest, ↓↓cell proliferation, cytostatic, 
↓tumor invasion, ↑ tumor differentiation 
in vitro 
(cell-based assays) 
in vivo 
(rat model) 
[73, 77] 
Nobiletin 
G1 arrest, ↓↓cell proliferation, ↑ 
apoptosis 
in vitro 
(cell-based assays) 
in vivo 
(rat model) 
[70, 74, 77] 
Hesperidin 
carcinogens detoxification, ↑ apoptosis, 
↓tumor invasion 
in vitro 
(cell-based assays) 
[70, 78, 79] 
Hesperetin G1 arrest, ↓cell proliferation, ↓ metastasis 
in vitro 
(cell-based assays) 
in vivo 
(mouse model) 
[70, 80-82] 
Sinensetin 
G2/M arrest ,↓cell proliferation, ↑ 
apoptosis, angiogenesis inhibition 
in vitro 
(cell-based assays) 
in vivo  
(zebrafish model) 
[70, 83, 84] 
Naringenin 
↓cell proliferation, ↑ apoptosis, ↓ 
metastasis 
in vitro 
(cell-based assays) 
in vivo 
(mouse model) 
[70, 82, 85] 
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1.2.3 Fruits of Prunus genus 
Prunus genus comprises more than 400 species of flowering shrubs and trees. Almond, 
peach, plum, cherry and apricot are the most economically relevant cultivars. 
Plums (Prunus domestica), peaches (Prunus persica) and sweet cherries (Prunus avium) are 
botanically and compositionally similar fruits. Previous works have reported their phenolic 
compounds, such as flavonols, anthocyanins, catechins and hydroxycinnamates in both peel 
and flesh [86, 87]. Besides, bioactive terpenoides have been also detected in several 
varieties of these fruits including perillyl alcohol, lutein and zeaxanthin [53, 88-90]. 
In recent years, cherry products have been in a continue demand in the food market 
because of their potential positive effects on health [91]. Sweet cherries contain significant 
amounts of phenolic compounds such as anthocyanins, which display a wide range of health 
promoting benefits [92, 93]. These nutraceutical compounds are not uniformly distributed 
in fruit tissue. High amounts of polyphenolics and anthocyanins are observed in the fruit 
skin due to their functions as photoprotective agents and attractants for seed dispersal [94].  
Prior researches have shown that anthocyanin members have anticancer activity [95, 96]. 
Antiproliferative activity in colorectal cancer cell lines was recently reported for several 
varieties of tart cherries [91]. Moreover, the value of cherries as fresh fruit is too high to be 
used for anthocyanins extraction [97]. The use of cherry wastes such as skins and pits from 
juice-processing industry represents a feasible alternative for these purposes.  
Besides, cherries exhibit a high content of perillyl alcohol, a monoterpene molecule which 
has chemotherapeutic proprieties against colorectal cancer [53, 98]. Perillyl alcohol has 
been shown to inhibit cancer cells migration and angiogenesis, two important processes in 
cancer dissemination [99, 100](described in section 1.3).  
Plums and peaches appear to have a wide range of health benefits, mostly due to their high 
content in antioxidant molecules such as neochlorogenic acid, protocatechuic acid and rutin 
[101-104]. Peach and plum extracts that have a high anthocyanin content can inhibit cancer 
proliferation and exert a differentiating effect [54]. This anthocyanins have demonstrated 
anti-tumorigenic  effects by several mechanisms, including apoptosis induction and cell 
cycle arrest at G1 phase [105]. 
In Table 1.4 are summarized the relevant phytochemical compounds detected in cherry, 
plum and peach. 
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Table 1.4: Reported anticancer activity for cherry, plum and peach phytochemical compounds. 
 
 
 
 
 
 
Phytochemicals Mechanism of anticancer activity Cancer model Ref 
T
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n
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Lutein 
and Zeaxanthin 
Carcinogens detoxification, ↑ apoptosis, 
angiogenesis inhibition, ↑ 
differentiation, ↓ ROS, modulation of 
immune response 
in vitro 
(cell-based assays) 
in vivo 
(mouse and rat 
models) 
[106] 
Perillyl alcohol 
Carcinogens detoxification, ↑ 
differentiation, ↑ apoptosis, 
↓proliferation, G1 arrest,  angiogenesis 
and migration inhibition 
in vitro 
(cell-based assays) 
in vivo 
(mouse and rat 
models) 
[49, 99, 
100, 107] 
P
h
e
n
o
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cs
 
Catechin 
↓Proliferation, ↑ apoptosis, ↓ ROS,  
angiogenesis and invasiveness 
inhibition 
in vitro 
(cell-based assays) 
in vivo 
(rat model and 
humans) 
[108, 
109] 
Rutin 
↓Proliferation, ↓ DNA damage, ↑ 
apoptosis 
in vitro 
(cell-based assays) 
in vivo 
(mouse and rat 
models) 
[110, 
111] 
Chlorogenic and 
Neochlorogenic 
acid 
↓Proliferation, invasion and migration 
inhibition 
in vitro 
(cell-based assays) 
[112, 
113] 
Protocatechuic 
acid 
Carcinogens detoxification, prevent 
DNA adduct formation, ↑ apoptosis , 
metastasis inhibition 
in vitro 
(cell-based assays) 
in vivo 
(mouse model) 
[101, 
114, 115] 
Anthocyanins 
G1 arrest, Carcinogens detoxification, ↑ 
apoptosis, ↓Proliferation, ↑ 
differentiation,  invasion and 
angiogenesis inhibition 
in vitro 
(cell-based assays) 
in vivo 
(mouse and rat 
models) 
[105, 
116, 117] 
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1.3 Cancer Cellular Models 
Drug development process typically comprises three major steps: i) drug discovery process; 
ii) pre-clinical studies and iii) clinical trials (phase I, II and III). Pre-clinical studies are the 
stage that precedes clinical trials with is testing the drug in humans. Discovery and pre-
clinical development is a continuous process resulting in preliminary pharmacology and 
toxicology studies [118]. In this phase the main goal is to evaluate product bioactivity, 
effectiveness, cytotoxicity, pharmacodynamics and pharmacokinetics. In the last two 
decades, several attempts have been made to develop cellular models to minimize the gap 
between cell-based assays and animal studies frequently used in pre-clinical phase. This 
allows a reducing of experimental uncertainties arising from traditional culture systems 
and, consequently, the cost of drug screening process [119]. 
Cellular models for colorectal cancer can display a unique tool to study tumors and their 
metastatic capacity. There are several adenocarcinoma cell lines derived from colon tumors 
at diverse points of differentiation and development stages. Tumor cell lines can be an 
important resource for understanding cancer initiation and progression. They present an 
identical spectrum of genetic alterations as primary tumors (described in section 1.1) [120]. 
In Table 1.5 is present the most common genetic alteration found in eight colon cancer cell 
lines. 
Table 1.5: Genetic alterations and mutated genes in several colon cancer cell lines [120]. 
Cell line Sex/age APC K-ras p53 β-catenin MMR 
Lovo M56 + + - - + 
HCT116 M? - + - + + 
SW48 F82 - - - + + 
HCT15 M? + + + - + 
LS1034 M54 + - + - - 
HT29 F44 + - + - - 
SW480 M51 + + + - - 
Colo320 F55 + + + - - 
 
During discovery phase and preclinical development of anticancer drugs, these are tested 
for their efficacy and potential, usually using cells grown in vitro on culture plates as 
monolayers (2D). Traditionally, 2D cell culture involves growing cells on solid, impermeable 
adherent surfaces. These monolayer cultures are easy and convenient to set up with high 
cell viability and have contributed greatly to our understanding of several diseases 
processes [121, 122]. However, these cellular models have many limitations and usually 
drugs do not work as effectively in vivo as in 2D model [121, 123]. Cell culture in 2D systems 
is a poor physiological model in comparison with in vivo systems, mainly due to the 
geometric differences between 2D culture and tissues, which are three-dimensional (3D) 
[124, 125]. Thus, the cells lose the capacity to respond to the molecular gradients in 2D 
[126]. It is, therefore, necessary to improve in vitro cell-based testing methods for a better 
perdition of drug candidate efficacy and safety [127]. 
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The lack of stroma and structural architecture are the main limitations of 2D monolayer 
models. Organ cultures could provide a better model, however, it is difficult to obtain 
specimens and the poor viability of  the tissues cultured are major obstacles [128].  
 
 
1.3.1 Three Dimensional Models  
3D cultures or multicellular tumor spheroids (MCTS) were first described, at the beginning 
of last century [129]. They were considered an improved in vitro model to simulate 
biological characteristics of tumor and consisted in 3D structures with a certain complexity 
[130]. The use of 3D in vitro systems has been recognized as a potential link to minimize the 
gap between monolayer cultures and animal model studies [127]. 
Tumor cells in spheroids show a higher degree of morphological and functional 
differentiation than in 2D culture [131]. One major advantage of 3D cancer models is their 
reproducible concentric arrangement of different cell populations which is an inherent 
property of solid tumors [132]. This gives a stratified composition, with proliferating cells in 
the outer rim, followed by a quiescent layer of cells and, eventually, necrotic cells in the 
spheroid center (Figure 1.9) [133]. Beyond altered gene expression and resistance to cancer 
treatment, the cell-cell and cell-matrix contacts in compact spheroid can also limit the 
diffusion of nutrients, oxygen and other compounds [125, 134]. In addition, poor efficiency 
of mass transport also leads to a metabolic waste accumulation inside the spheroids, like in 
vivo tumors [135]. 
 
 
Figure 1.9: Multicellular tumor spheroid scheme. Cells are organized forming a sphere spheroid with 
different zones, a proliferative, quiescent and central necrotic area. Oxygen, nutrients and 
proliferation gradients are indicated [136]. 
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Co-cultivation of multiple cell types is possible in 3D cultures, allowing the study of the 
interactions between epithelial and stromal cells, such as fibroblasts, which regulate normal 
and neoplastic development. The interactions and support from stromal elements and ECM 
plays a crucial role in tumor biology. These parameters can determine the behavior and 
gene expression of the cells [137]. Cell shape and tissue architecture depends on various 
adhesion molecules, consequently, every alteration in these molecules has relevance to 
cancer environment [138]. Therefore, recapitulating these in vitro can potentially minimize 
the relevance of in vitro models and better mimic of the in vivo like response to cancer 
therapies. The culture of colon cancer spheroids has been described since 1986 and has 
already been used for multiple in vitro studies [139-141]. However, co-cultures of colon 
cancer cells with cancer associated fibroblasts have been described only recently [142, 143]. 
The cell-cell and cell-matrix interactions in the complex 3D model not only affects drug 
action and penetration but it is also essential in the distribution and function of 
physiologically occurring factors. These biochemical effectors that play an important role in 
the regulatory mechanisms of cell growth, differentiation and death include hormones and 
growth factors. This microenvironment is important for the regulation of normal cell 
function and it may be useful to understand how it regulates tumorigenic phenotypes, 
structural and biochemically. Despite the complexities of 3D spheroids co-cultures, these 
models provide a strong complementary use to the animal models [137]. 
There are several methodologies to achieved 3D culture from cell lines, primary cells and 
organs, including spontaneous aggregation, liquid overlay cultures, and stirred culture 
systems [137]. The advantages and disadvantages for each culture systems, depending on 
the type of experiment and the final model. It is important to take in consideration the 
increased time and cost of experimental set-up and the model optimization and validation 
(Table 1.6) [122].  
Traditionally, spheroids were obtained by spontaneous cell aggregation, generating 
spherical cellular conglomerates. Spheroids formed by this technique are analogous to 
avascular tumor nodules in terms of growth kinetic, with populations of proliferating, 
quiescent and necrotic cells. These different cell populations appear mostly due to mass 
transport limitations and also recreate the situation observed in intravascular microregions 
of large tumors or micrometastases prior to vascularization [144]. Other similar way to get 
3D spheroids is ensuring conditions in which the adhesive forces between the cells are 
greater than the substrate plated on. Liquid overlay techniques (forced-floating and hanging 
drop methods) promotes a spontaneous aggregation, preventing cell matrix deposition. 
Thus, spheroids formations can even be induced in cell lines which are difficult to aggregate 
(Figure 1.10 (a) and (b)) [145]. 
Stirred culture systems present great advantages to grow 3D spheroids. These methods 
include gyratory rotation, rotary cultures, rotating-wall vessel bioreactor (RWV) and 
stirred-tank systems such as spinner flasks. In contrast to the static environment of liquid 
overlay cultures, which are useful to study the individual spheroid, the dynamic suspension 
of spinner flasks allows the production of larger numbers of spheroids. The spinner’s 
impeller mixes and maintains the cells in suspension creating a fluid movement that is 
engineered to aid mass transport of nutrients to the center of spheroid (Figure 1.10 (d)). 
Spinner flask culture was the most widely used method for culturing large numbers of 
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multicellular tumor spheroids. However, other successful methods, including gyratory 
shakers have also been used, as well as, RWV bioreactor which maintains cells in a dynamic 
fluid suspension mixed by minimal hydrodynamic forces. The culture flask rotates whole on 
its horizontal axis, providing the mixing of the cells. The vessel is completely filled with 
medium minimizing fluid turbulence and shear forces with a semi-permeable membrane 
providing aeration and the elimination of bubbles (Figure 1.10 (c)) [146, 147].  
 
Figure 1.10: Common methods for multicellular spheroid formation: (a) forced floating, (b) hanging 
drop, (c) rotating-wall vessel bioreactor and using (d) spinner vessel bioreactor. (adapted from 
[148]) 
Finally, 3D cultures in environmental controlled stirred-tank bioreactors working in 
perfusion mode have been developed for culture and analysis of 3D tissues. These systems 
allow an automatic replenishment of exhausted media and control the addition of fresh 
medium. Further, it enables a tight regulation of extracellular environment including fluid 
shear and the concentration gradients of biochemical molecules. Besides the control of 
temperature, pH, oxygen, nutrients and metabolites, bioreactors allow the automatic 
feeding and effective mass transfer [149, 150].  
In addition to the spheroid culture, various alternative cell culture strategies are available 
as tools for engineering 3D models, including the use of microcarrier beads as scaffolds. 
Microcarriers have provided many advantages to cell culture such as supporting the 
aggregation of attachment dependent cells and cell lines which do not spontaneously 
spheroid. Furthermore, microcarriers can be used as a platform to co-culture different cell 
types [137, 151]. Scaffolds are often used with the possibility of adding growth and 
regulatory factors. In the past decade, enhanced scaffolds have been introduced as 
improved support in natural molecules (collagen composite), synthetic/semi-synthetic 
polymers (polyethylene glycol or hydrogels) or a combination of these materials. The major 
advantage of these scaffolds is the great potential to recreate the natural physical and 
structural environment of living tissue. Has been demonstrated to promote signalling 
pathways that regulate migration, proliferation and differentiation [152-154] . 
Liquid overlayer techniques
Stirred systems
Non adhesive coating
(a) (b)
Centrifugation
Spheroids in hanging drop
(d)(c)
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In Table 1.6 the main advantages and disadvantages of common 3D cell culture systems are 
summarized. 
 
Table 1.6: Major advantages and disadvantages of common 3D culture methods. 
Culture system Advantages  Disadvantages 
Static systems 
 Relatively simple 
 Inexpensive 
 Suitable for high-
throughout 
 Spheroids production are 
easily accessible 
 
 Labor intensive 
 Small culture volumes difficult 
medium exchange without 
disturbing cells 
 No control over size of spheroid 
Stirred  
systems 
 Simple to culture 
 Large-scale production 
easily achievable 
 Better nutrient transport 
 Spheroids production are 
easily accessible 
 
 Specialized equipment required 
 No control over size of spheroid 
 Cells are exposed to shear 
stress forces in spinner flasks 
(problematic to sensitive cells) 
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1.4 Thesis Goal 
 
The major goal of this thesis is the evaluation of the anticancer effect of phytochemical 
extracts, using 3D cellular model of colon cancer. For this propose a 3D model using HT29 
cells growing as spheroids was developed and characterized. 
The work was divided in three major parts as schematically presented in Figure 1.11. 
 
Figure 1.11: Structure of the thesis. 
 
In the first part, the antiproliferative effect of natural extracts obtained from cherries, 
peaches, plums, oranges and olive seeds were tested in 2D monolayer cultures. 2D dose-
response curves were performed to determine the effective dose value (EC50) of each 
extract. In this part, phytochemical characterization of the extracts was also carried out. 
The second part was focused in the development of 3D cell model of colon cancer using 
dynamic stirred culture system. Tumor spheroids were grown in spinner flasks and several 
culture parameters were optimized. Phenotypic assessment was also performed in order to 
better characterize the 3D cell model.   
In the third part of the work, chemotherapeutic potential of the most promising 
phytochemical-rich extracts were evaluated using 3D model of colon cancer and results 
were compared with 2D monolayer results.  
 
 
 
Part 1
Part 2
Screening of natural extracts
3D Model development
Evaluation of anticancer 
effect  of natural extracts 
using  3D cell models
• Antiproliferative effect using 2D cell cultures
• Phytochemical characterization
• HT29 spheroids generation
• Phenotypic characterization
• Antiproliferative effect
• Cell cycle arrest
• Induction of apoptosis
Part 3
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2 Experimental Procedure 
 
2.1 Natural extracts 
Olive seeds extracts from six olive trees varieties (Cobrançosa, Zambujeiro, Picual, Arbosana, 
Koroneiki and Arbequina) were performed by conventional solvent extraction (CSE) in the 
context of an ongoing project [155]. 
Initially, the seeds were obtained by breaking the olive stones. The solid-liquid extraction 
was carried out using 2 g of each seed sample and 10 ml of solvent mixture containing 
EtOH:H2O (80:20,v/v). Samples were mixed by vortex during 5 minutes and then 
centrifuged for 15 min at 5000 rpm. The extraction procedure was repeated once again and 
finally supernatant was filtered and concentrated by rotary evaporator. Samples were 
dissolved in EtOH:H2O (80:20,v/v) and stored at -20 0C after being filtered through a 0.45 
µm filter Acrodisc® (Pall, USA). 
Extracts of cherry, plum, peach and orange residues were performed by Nutraceuticals and 
Delivery group of IBET (Oeiras, Portugal) using high pressure technology. All of the raw-
materials used for extraction are residues of fruit juice production (peels, seeds and core), 
or crop residue (cherry culls). The extracts were obtained under variable extractions 
conditions and using diverse CO2/EtOH ratios. 
In Table 2.1 are summarized the extraction conditions used to obtain high pressure natural 
extracts. 
Table 2.1 : Extraction conditions used to obtain fruit residues extracts with high pressure technology. 
Extract 
CO2 pre 
treatment 
Pressure 
(MPa) 
Temperature 
(K) 
Time 
(min) 
% 
CO2/EtOH 
Ref 
Orange peel - 25 323 
30; 60; 
90;120 
80/20 [156] 
Cherries 60 min 25 323 30 90/10 [90] 
Peach 60 min 25 323 30 90/10 [90] 
Plum 60 min 25 323 30 90/10 [90] 
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2.2 Phytochemical characterization 
2.2.1 Terpenes analysis by thin layer chromatography (TLC) 
The detection of terpenes, such as perillyl alcohol and linalool, was performed by thin layer 
chromatography (TLC). 
TLC analysis was carried using silica gel plates with a 254 nm fluorescent indicator with 
aluminum base (20 cm x 20 cm) (Macherey-Nagel, Duren, Germany).  Dichoromethane was 
used as mobil phase and for detection a mixture of 1% ethanolic vanillin + 10% ethanolic 
sulphuric acid + Burchard reagent (1% acetic anhydride and 1% suphuric acid ethanolic) 
was applied. At the end of elution, the plate was sprayed with prepared solutions and 
heated at 110 0C for 10 minutes. Then, the plate was revealed with Burchard reagent and 
the visualization was performed under 254 nm UV light.  
 
 
2.2.2 Phenolic analysis by high performance liquid chromatography (HPLC)  
The phenolic HPLC analysis of natural extracts was performed by Analytical Group of IBET 
(Oeiras, Portugal) coordinated by Dr. Rosário Bronze. Briefly the analysis was carried out 
using a Surveyor apparatus form Thermo Finnigan with a diode array detector (Thermo 
Finnigan-Surveyor, San Jose, CA, USA) and an electrochemical detector (Dionex, ED40) 
[157]. Separations were performed at 35 0C in a LiChrospher C18 (5 µm, 250 mm x 4 mm 
i.d.) column from Merck with a guard column of the same type. The samples injection was 
carried out using a 20 µl loop. The gradient mobile phase consisted of eluent A (phosphoric 
acid (0.1%)) and eluent B (phosphoric acid (0.1%)-acetonitrile-water 1:900:99, v/v/v) at a 
flow rate of 700 µl/min. The following eluents gradient was used: 0.10-25 min from 0 until 
8.9% eluent B; 25-70 min, from 8.9 until 31.1% eluent B; 70-75 min, with 31.1% eluent B; 
75-85 min from 31.1 until 44.4% eluent B; 85-90 min, with 44.4% eluent B; 90-125 min 
from 44.4 until 90% eluent B; 125-130 min, with 90% eluent B; 130-131 min from 90 until 
100% eluent B; 131-145 min, with 100% eluent B. Diode array detection was performed 
between 192 and 798 nm. The data acquisition system used was the Chromquest version 
4.0 (Thermo Finnigan-Surveyor, San Jose, CA, USA). Chromatograms recorded at 280 nm 
were used to analyze total phenolics. Identification of compounds was done by comparing 
retention time and spectra with known amounts of pure standards (ferulic acid, vanillin and 
naringenin). Total polyphenol content of samples was determined using total peak area 
recorded at 280nm and a calibration curve with gallic acid (10-100 mg/L). Final results 
were expressed as gallic acid equivalents per liter of extract. 
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2.3 Cell-based assays 
2.3.1 Cell lines and culture 
Human colon cancer cell lines, HT29 and Caco2 were provided by American type Culture 
Collection (ATCC, USA) and Deutsche Sammlung von Microorganismen und Zellkulturen 
(DSMZ, Germany), respectively. Both cell lines were cultured in RPMI 1640 medium 
supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 2 mM of glutamine. 
Cells were kept at 37 0C in a humidified incubator with 5% CO2 and routinely grown in 75 or 
175 cm2 culture flasks.  Cell culture medium and supplements were obtained from 
Invitrogene (Gibco, Invitrogene Corporation, Paisley, UK).  The cell lines were split once or 
twice a week, the morphology and growth of cells were monitored daily. 
 
 
2.3.2 Antiproliferative assay using 2D cell culture system 
Antiproliferative assays were performed on human colon adenocarcionoma cell line (HT29) 
growth as monolayer. 
The assay was carried out in 96-well microplates as described by Serra et al. [53]. Briefly 
cells were seeded at a cellular density of 1x104 cell/well. After 24 hours of incubation in 5% 
CO2 humidified atmosphere at 37 OC the medium was removed and cells were incubated 
with natural extracts diluted in RPMI medium supplemented with 0.5% FBS. After 24 hours, 
the medium was removed and cell viability was assessed using commercial PrestoBlue® 
Viability Reagent (Molecular Probes, Invitrogen, US). Briefly, PrestoBlue® regent (diluted 
1:10) was added to each well and the microplate was incubated for 2 hours. Finally the 
fluoresce was quantified on a microplate fluorescent reader (FL800, Bioteck Instruments, 
USA) with filter appropriate for 580 nm excitation and 595 nm emission maxima. The 
results were expressed as a percentage of cell viability relative to the control (cells 
incubated with culture medium only, without natural extracts). The experiment was 
performed in triplicate. EC50 values (the concentration of sample necessary to decrease 
50% of cell viability) were obtained from dose-response curves using software GraphPad 
Prism (GraphPad Software, Inc., La Jolla, CA) fit. 
 
 
2.3.3 Cytotoxicity assay 
In vitro cytotoxicity assays were accomplished using confluent Caco2 cells. Despite were 
obtained from a human colon adenocarcionoma, this cells can be used as an intestinal 
barrier model when cultured under special conditions. When Caco2 becomes differentiated 
and polarized, it shows a resemblance morphological and functional to enterocytes from 
small intestine. Their differentiation occurs spontaneously when cells grow in monolayer in 
a long term culture [158]. 
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Cells are seeded into 96-well culture plates at a density of 2x104 cell/well, and were allowed 
to grow for 8 days, with medium exchange every 48 hours. Extract samples, previously 
diluted in culture medium (RPMI with 0.5% FBS and 2mM glutamine), were added to all 
wells except to the control samples. Incubation with natural extracts was carried out during 
24 hours and cytotoxicity evaluation was performed with PrestoBlue® Viability Reagent 
(Molecular Probes, Invitrogen, US). PrestoBlue® regent (diluted 1:10) was added to each 
well and the microplate was incubated for 2 hours. Finally the fluorescence was quantified 
on a microplate fluorescent reader (FL800, Bioteck Instruments, USA) with filter 
appropriate for 580 nm excitation and 595 nm emission maxima. Viability, expressed as 
percentage of living cells, was determinate relatively to the control. IC50 values were 
calculated from dose-response curves using software GraphPad Prism (GraphPad Software, 
Inc., La Jolla, CA) fit.  
 
 
2.3.4 Cell culture and spheroids formation  
Cells grown as a monolayer were detached with trypsin/EDTA and a density of 2.5x105 
cell/ml was placed into the 125 ml spinner flasks (Proculture, Corning, NY, USA). To prevent 
the walls attachment, spinner flasks were pre-coated with 2-3 ml of dimethyldichlorosilane 
(Merck 8.03452, Germany). The spinner flasks were placed on a magnetic stirrer and were 
maintained in culture for 12 days. Initially, a stirring rate of 40 rpm with only 60% of total 
volume (75 ml) was used until 8 hours after inoculation, aiming at promoting spheroids 
formation. To control the size of the spheroids, the stirring rates were gradually increased 
for 45, 50, 55 and finally 60 rpm at 8, 10, 24 and 28 hours post-inoculation, respectively. 
After that, aggregation kinetic was daily monitored until day 7 of culture. At day 3, the first 
medium exchange was performed (50% of spinner flask culture medium was replaced by 
fresh medium). This was a daily procedure. The culture was monitored counting nuclei, 
viable cells and measuring spheroids diameter.  
 
 
2.3.5 Cell viability and total cell count 
Total cell number assessment on culture is indispensable to evaluate the aggregation 
process and it is useful to draw conclusions about the dissociation method. In order to 
determine the total cell number present in the culture, their nuclei were counted using 
crystal violet method that stains nuclei in purple. Cells were previously lysed by adding lysis 
buffer (1% Triton X-100 in 0.1 M citric acid), at least 15 minutes, at 37 0C. Nuclei were 
stained in 0.1% of crystal violet. 
To assess cell viability, the spheroids were centrifuged during 5 minutes at 200x g followed 
by washing with PBS and dissociation by adding trypsin-EDTA 0.05%. 4 minutes later, cells 
were resuspended in culture media (RPMI 1640 with 10% of FBS), in order to inactivate 
trypsin, diluted and stained with trypan blue 0.1% (Gibco, Invitrogene Corporation, Paisley, 
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UK). Cells with damaged membrane (non viable) are stained by trypan blue, while viable 
cells are not stained and therefore appear bright. Cell viability and nuclei count were 
performed using a hemacytometer. 
In addition, spheroids viability was qualitatively assessed using fluorescent dyes, FDA and 
PI, to stain viable and non viable cells. Fluorescein diacetate (FDA) is a cell viability probe 
that measures esterase enzymatic activity, which activate its fluorescence, and cell 
membrane integrity, allowing intracellular retention of their fluorescent product. This dye 
exhibits a green fluorescence that stains viable cells. PI is a nuclear red-fluorescent molecule 
which is membrane impermeant excluded from viable cells. This probe only stains nucleus 
of membrane-compromised cells and intercalate into its double-stranded nucleic acids. 
Spheroids were stained with both FDA and PI, diluted 1:1000 and analyzed using 
fluorescence microscope (Leica DM6000). Thus, viable cells present green fluorescence and 
non viable red fluorescence. 
 
 
2.3.6 Analysis of spheroids size and shape  
During the spheroids formation process, a regular monitoring is required in order to 
determine spheroids size. 
Using fluorescein diacetate and propidium iodide it was possible to observe viable and non-
viable cells, as previously described. Colonospheres were also observed by bright field 
microscopy (Leica DM6000). Their average diameter was determined using ImageJ 
software. Ferret diameter was calculated for each spheroid with more than 50 µm diameter. 
 
 
2.3.7 Flow cytometry  immunophenotyping 
Aiming to identify the stem cell-like character of 3D model, the quantification of CD44+ cells 
was carried out. Antibody anti-CD44 was used to detect cells that contain expression of 
CD44 antigen. The quantification of cell population was performed using the fluorochrome 
R-Phycoerythrin (PE), which is coupled with the antibody. 
Briefly, spheroids were harvested (5x105 cell) and detached as described previously 
(section 2.3.5). Single cells were sedimented by centrifugation at 500x g (Mikro 220R, 
Hettich, Tuttlingen, Germany) for 5 minutes followed by washing with 500 µl of cold FACS 
buffer (PBS supplemented with 1% FBS) and incubation with antibody anti-CD44-PE 
(eBioscience) diluted 1:20 (0.1 µg/0.5x106 cell) in FACS buffer for 1 hour at 4 0C. Isotype 
control was used in the same proportion to evaluate the existence of unspecific bindings. 
After the incubation time, cells were washed twice again with 500 µl of cold FACS buffer. 
The pellet was resuspended in 2 ml of FACS buffer and storage at 4 0C until the 
measurement in flow cytometer. Results were acquired in CyFlow space instrument (Partec, 
Germany). The parameters in the flow cytometer were adjusted with the corresponding 
isotype control antibody (IgG2b) conjugated with PE, serving as a negative control, and it 
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was acquired a total of 15000 events per sample in order to identify the expression of CD44 
surface marker.  
 
 
2.3.8 Immunofluorescence microscopy 
Tumor spheroids were collected from the suspension culture and immediately fixed in 4% 
(w/v) paraformaldehyde (PFA) and 4% (w/v) sucrose solution in PBS for 30 minutes. After 
2 washes with PBS, spheroids were dehydrated in PBS solution with 30% of sucrose. For the 
cryosectioning, colonospheres were frozen at -80 C in Tissue Teck OCTtm (Sakura) and were 
sectioned in cryostat (Leica) in sections of 10 µm. 
For 2D controls HT29 cells were cultured as monolayer in glass coverslips, inoculated at 
1x104 cell/well. After 24 hours of seeding, cells were gently washed with PBS and fixed with 
4% (w/v) PFA solution in PBS with 4% (w/v) sucrose for 20 minutes. 
Cryosections and 2D controls were initially washed twice with PBS followed by 
permeabilization with 0.1% Tx-100 solution in PBS for 10 minutes. At the end of 
permeabilization step, cells were washed 2 times with PBS and blocked with 0.2% of FSG in 
PBS for 30 minutes. Primary antibody was diluted in 0.2% FSG solution and it was added to 
the cells and they were incubated during 2 hours. After 2 washes with PBS, cells were 
incubated for 1 hour with secondary antibody in 0.2% FSG solution. The list of primary and 
secondary antibodies is presented in Table 2.2. Cryosections were finally washed twice with 
PBS, mounted in ProLong mounting medium contain DAPI (Invitrogen) and visualized using 
a fluoresce microscope (Leica DM6000, Germany). Besides the antibodies, it was also used 
Alexa Fluor® 488 Phalloidin (invitrogen) diluted 1:100, a bicyclic peptide, which binds F-
actin with high selectivity and presents green fluorescence due to the presence of Alexa 
Fluor® 488. 
 
 
 
 
 
 
 
 
 
 
29 
 
Table 2.2 : List of antibodies and respective dilutions used for immunofluorescence microscopy 
assays 
Antibody Marker Concentration Manufacturer 
Anti-vimentin Mesenchymal cells 1:200 Sigma 
 
Anti-Cytokeratin 
18-FITC 
Epithelial cells 1:100 Sigma 
Anti-E-Cadherin Epithelial cells 1:300 BD 
Anti-β-Catenin 
Cytoplasmatic/nuclear 
localization - EMT 
1:200 Santa Cruz Biotechnology 
Anti-CD44-PE Cancer stem cells 1:50 eBioscience 
M30 cytoDEATH Early apoptosis 1:30 Roche 
Anti-mouse Alexa 
Fluor 488 
(secondary antibody) 1:500 Invitrogen 
Anti-rabbit Alexa 
Fluor 594 
(secondary antibody) 1:500 Invitrogen 
 
 
2.3.9 Antiproliferative assay using 3D culture systems 
Before the evaluation of antiproliferative effect of natural extracts on colonospheres several 
viability assays were studied, such as, CellTiter 96® Aqueous One and PrestoBlue®. To 
assess reagent diffusion and the range of linearity of each method, standard curves were 
tested using different spheroids densities and sizes. The spheroids were diluted in culture 
media (RPMI with 10% FBS and 2mM glutamine) and placed in 96-well plate pre-coated 
with Poly-L-Lysine (10 µg/ml) followed by the addition of respective viability reagent (see 
appendix A). These methods were applied for three spheroid sizes, 300, 400 and 500 µm of 
diameter. 
Antiproliferative assays were performed using natural extracts and HT29 spheroids with 
300, 400 and 500 µm of diameter that were cultured in spinner flasks during 3, 5 and 7 
days. 
Cell spheroids were seeded at a density of approximately 4 spheroid/well, in 96-well 
microplates pre-coated with Poly-L-Lysine (10 µg/ml). Cell viability was assessed using 
PrestoBlue® reagent. This measurement was essential to estimate the number of cell in each 
well. Briefly, 10 µl of PrestoBlue® was added to each well. After an incubation period of 2 
hours, well plate was centrifuged (SIGMA 3K15, Sigma Laborzentrifugen, Germany) for 4 
minutes at 200x g and supernatant was placed into a black-96-well microplate to measure 
fluorescence intensity. Orange peel (fraction 30 min) and Brooks cherry extracts, previously 
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diluted in RPMI culture medium supplemented with 0.5% FBS, were added to each well and 
incubated for 24 or 72 hours. After that, extracts were removed and PrestoBlue® diluted in 
culture media was added according supplier protocol. PrestoBlue® viability reagent 
fluoresce was measured by microplate fluorescence reader (FL800, Bioteck Instruments, 
USA) at an excitation and emission wavelengths of 580 and 595 nm, respectively. 
The assay was made using 6 replicates of each extract concentration and results were 
expressed in terms of percentage of growth inhibition, in relation with control 
(colonospheres without extract incubation).  Cell viability was calculated using following 
equations:  
 
Where FI0 is the fluorescence intensity of cells before incubation with extract and FI24/72 is 
fluorescence intensity of cells after 24 or 72 hours of extract incubation. 
All EC50 were calculated from dose-response curves using software GraphPad Prism 
(GraphPad Software, Inc., La Jolla, CA) fit.  
 
 
2.3.10 Apoptotic activity 
The assessment of cells apoptotic activity can provide important complementary 
information about drug’s chemotherapeutic effectiveness. 
Apoptotic activity of natural extracts on colonspheres was performed with NucViewTM 488, 
caspase-3 substrate, and MitoViewTM 633, red-fluorescent mitochondrial dye. Caspase-3 
substrate, which is non-fluorescent and non DNA dye, penetrates on cell membrane and it is 
cleaved by caspase-3/7 in cytoplasm, forming a high-affinity DNA dye. This DNA probe 
migrates to cell nucleus originating bright green stain. Besides, NucViewTM 488 is able to 
stain cell nuclei, which undergo morphological changes during apoptosis. Consequently, 
apoptotic cells display a lower red fluorescence signal and higher green fluorescence when 
compared with non-apoptotic cells. 
In this experiment tumor spheroids were placed in a 24 well-plate at a density of 100 
spheroids/well and Orange peel (0.5 mg extract/ml) and Brooks cherry (0.1 mg extract/ 
ml) extracts were added. Cells were kept during 24 hours in a humidified atmosphere at 
37oC with 5% CO2. At the end of the exposure period, supernatant was removed followed by 
the addition of 200 µl of fresh culture medium containing 1µl of each dye (NucViewTM 488 
and MitoViewTM 633). During 2 hours, cells were stained with fluorescent dyes. The plate 
was centrifuged (SIGMA 3K15, Sigma Laborzentrifugen, Germany) for 5 minutes at 200x g 
and cells were washed with PBS. Spheroids were resuspended in PBS (200 µl) and observed 
in fluorescence microscope (Leica DM6000, Germany) and in spinning-disc confocal 
microscope (Nikon Eclipse Ti-E, Japan). 
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2.3.11 Cell cycle assessment  
Using flow cytometry is possible to distinguish cells in different phases of the cell cycle.  By 
fluorescence labeling of cell’s nuclei in a suspension, it is possible to correlate fluorescence 
intensity with the amount of DNA that they contain. Cells in G1 phase will have one copy of 
DNA, consequently they will have the half of fluorescence intensity when compared with 
cells in phase G2/M, which contain two copies of DNA. Since the cells in phase S are 
synthesizing DNA, they present intermediate fluorescence intensity. 
Cell cycle analysis was performed by fluorescence-activated cell sorter (FACS) using 
propidium iodide (PI) as a dye. Briefly, 1 ml of spheroids suspension containing 
approximately 100 colonospheres was collected from spinner at day 7 of culture and placed 
in a 12-well plate. During 24 hours, all the cells were incubated with orange peel (fraction 
30 min) and Brooks cherry extracts (0.63 mg extract/ml for orange and 0.18 mg extract/ml 
for cherry), except control cells that were incubated with culture medium, alone or culture 
medium plus solvent. After that, spheroids were transferred to centrifuge tubes and 
centrifuged at 200x g during 5 minutes. The supernatant was removed and the pellet was 
washed with PBS. Spheroids were then dissociated with 200 µl of trypsin/EDTA 0.05% for 3 
minutes followed by addition of 800 µl of RPMI medium (10% FBS) for an efficient trypsin 
inactivation. Cells were centrifuged at 200g for 10 minutes. After that supernatant was 
removed, cells were washed with cold PBS and centrifuged again (200x g, 10 min). Cells, at a 
density of 1x106, were incubated with 1 ml of a solution containing PI (50 mg/ml), Triton-x 
10x (1.5%), ribonuclease A (0,7 U/ml) and NaCl (0.01M) overnight at 4 0C. Analysis was 
carried out using a flow cytometer (CyFlow Space, Partec, Germany) and cell cycle analysis 
was done using software FlowMax cell cycle platform (Partec, Germany).  
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3 Results and Discussion 
 
Recently, special interest has been focused on the recovery of wastes in an effort to find 
value added applications to these residues. In this thesis, natural extracts produced by clean 
extraction technologies from waste residues of fruit processing industry/ crops were 
evaluated in terms of their potential chemotherapeutic effect using 2D and further 3D cell 
models of human colorectal cancer cell line HT29.  
 
3.1 Screening of the antiproliferative effect of natural extracts 
In this work, several natural extracts obtained by different extraction methods as well as 
different extraction conditions, were screened for their antiproliferative effect.  The 
selection of samples was based on previous studies related with the anticancer potential of 
raw material and the efficacy of extraction technologies to isolate the bioactive molecules. 
 
3.1.1 Olive seed extracts 
Initially, olive seed extracts, obtained by conventional solvent extraction (80:20 
etanol:water v/v) from six varieties, namely Cobrançosa, Arbequina, Arbosana, Koroneiki, 
Picual and Zambujeiro were explored as potential sources of bioactive molecules.  Figure 3.1 
presents the phenolic profiles of all samples obtained by HPLC-DAD. 
 
Figure 3.1 : Phenolic profiles of CSE extracts of olive seeds obtained by HPLC-DAD recorded at 280 
nm. Legend: 1- nuzhenide; 2- oleuropein. 
Results showed that phenolic profiles of different olive seed varieties were very similar, 
however, some variations in peaks intensity were observed.  Nuzhenide and oleuropein that 
were previously identified in olive seed composition, were the main phenolic compounds 
identified in all extracts [62].  
Nuzhenide content of all samples, as well as total phenolic concentration, was also 
determined by HPLC and results are presented in Table 3.1. 
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Table 3.1 : Phytochemical characterization of olive extracts. 
CSE extract 
TPC * 
(mg GAE/L extract) 
Nuzhenide ** 
 (mg OE/L) 
Cobrançosa 76.98 94.77 
Arbequina 23.77 29.00 
Arbosana 42.25 62.14 
Koroneiki 17.94 44.07 
Picual 75.94 151.65 
Zambujeiro 39.84 173.99 
* Total phenolic content (TPC) was determined using total phenolic peaks area and gallic acid 
standard curve. The results are expressed in mg of gallic acid equivalents/L of extract. 
** Nuzhenide content was determined using total nuzhenide peak area using oleuropein standard 
curve. The results were expressed in mg of oleuropein equivalents/L of extract. 
 
Among all extracts, Cobrançosa and Picual displayed the highest phenolic amount, whereas 
Koroneiki presented the lowest concentration in phenolic compounds. Zambujeiro extract 
was the one that presented the highest concentration of nuzhenide. 
The antiproliferative effect of all samples was evaluated in HT29 cells and results showed 
that only Zambujeiro extract was able to inhibit HT29 cells growth (Figure 3.2). 
 
 
Figure 3.2: Antiproliferative effect of extracts from olive seeds varieties on human colon cancer cells 
HT29 (incubation time:24 h; Data are means ± SD (n=3)).  
For this sample, the effective dose value (EC50) was 4.084 (% v/v). It is important to 
highlight that this extract was not cytotoxic in Caco2 cells, which are a good model of 
intestinal barrier. 
When compared with phytochemical characterization of the extracts, it could be suggested 
that the higher antiproliferative response could be related with the presence of high 
nuzhenide content. Nuzhenide is a phenolic compound commonly present in this type of 
natural sources, but, up to now, there is no information about health benefits. 
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Further studies should be performed in order to identify the main bioactive compounds of 
Zambujeiro extract. Moreover, since the EC50 value is relatively high, other extraction 
techniques should be explored to isolate the main bioactive compounds responsible for the 
anticancer effect. 
 
3.1.2 Fruit residues extracts 
Natural extracts from orange peel, plum, peach and cherries waste residues were performed 
by high pressure technology. It is important to note that this technology allows an easier 
and more selective extraction of phytochemical compounds from natural sources than 
others conventional methods [155]. 
Orange juice industry waste residues, namely orange peel, present a flavonoid-rich 
composition that are already reported to exhibit high anticancer effect [70]. In this work, 
orange peel extracts produced by high pressure extraction using pressure, temperature and 
co-solvent conditions already reported to efficiently isolate PMFs, were evaluated for their 
antiproliferative effect (Table 2.1) [156]. Samples were obtained at different extraction 
times in order to select the most effective fraction to inhibit proliferation of HT29 cancer 
cells. 
Orange peel extracts collected after 30, 60, 90 and 120 minutes of extraction were 
characterized in terms of phenolic profile. Figure 3.3 shows the phenolic content of all 
factions. 
 
Figure 3.3: Phenolic profiles of all orange peel fractions. The results were obtained by HPLC-DAD-UV 
recorded at 280 nm. Legend: 1- ferulic acid; 2- sinensetin; 3- nobiletin; 4- tangeretin 
Phenolic profiles of all orange peel extracts were similar, although the fraction collected in 
the first 30 minutes of extraction (1st fraction) presented the highest peaks intensity.  
In order to complement this phytochemical characterization, the total phenolic content was 
determined (Table 3.2). These results confirm the high phenolic content of the first extract 
fraction (30 minutes). 
 
36 
 
Table 3.2: Total phenolic content of orange peel extracts 
Orange Peel extracts 
TPC* 
(mg GAE/L extract) 
1st  fraction (30 min)  2205.9 
2nd  fraction (60 min) 451.84 
3rd  fraction (90 min) 226.13 
4th  fraction (120 min) 225.76 
* Total phenolic content (TPC) was determined using total phenolic peaks area using gallic acid 
standard curve. The results are expressed in mg of gallic acid equivalents/L of extract. 
 
In fact, the first fraction had 5 to 10 times more phenolic content than the other orange 
fractions (Table 3.2). 
The antiproliferative effect was also evaluated and the extract collected in the first 30 
minutes of extraction displayed the highest anticancer activity with an effective dose value 
of 0.488 ± 0.031 mg extract/ml (Figure 3.4). 
 
Figure 3.4: Antiproliferative effect after 24 hours of incubation with orange peel fractions collected at 
different extraction times on HT29 cell line. Results were mean ± SD (n=3). 
Results presented in Figure 3.4 also showed that the antiproliferative effect of extract 
samples decreased with the extraction time, indicating that the main bioactive compounds 
were selectively extracted during the first 30 minutes of process. These findings are in 
accordance with the phytochemical composition, in particular, PMFs content of orange 
extracts. Sinensetin, nobiletin and tangeretin were some PMFs detected in high 
concentration in the 1st fraction of orange peel extract. These compounds are already 
reported to exhibit antiproliferative effect on gastric and colon cancer cell lines [70, 83]. 
Additionally, PMFs present low polarity and planar structure. These features enhance their 
biological activity due to the high membrane permeability and binding proprieties [70]. 
In the case of cherries, the extracts were obtained using a fractioned high pressure 
extraction process previously optimized to isolate perillyl alcohol-rich fractions from this 
type of raw material [53]. Cherry extracts used in this work were derived from two different 
cherry varieties, Brooks and Sweet Heart. Since plums and peaches belong to the same 
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genus (Prunus) of cherries, they also present similar composition. Therefore, extracts 
derived from plum and peach residues were performed using the same extraction process 
and were also tested in this study. 
Terpenes composition of plum, peach and cherry extracts (Sweet Heart and Brooks 
extracts), was evaluated by TLC (see appendix B). The methodology allowed the detection of 
perillyl alcohol in all the analyzed extracts. 
The phenolic profiles were analyzed by HPLC-DAD and the main compounds identified 
include vanillin and naringenin in peach extract and sakuranin in both cherry extracts 
(Figure 3.5).  
 
Figure 3.5: Phenolic profiles of plum and peach (A) and both cherry extracts (B). The results were 
obtained by HPLC-DAD-UV recorded at 280 nm. Legend: 1- vanillin; 2- naringenin; 3- sakuranin. 
Aiming at comparing all extracts, the total phenolic content was assessed by HPLC and the 
results are presented in Table 3.3. 
Table 3.3: Phenolic characterization of Prunus extracts 
Prunus extract 
TPC* 
(mg GAE/L extract) 
Sweet Heart cherry 74.0 
Brooks cherry 1049.9 
Plum 118.5 
Peach 308.0 
* Total phenolic content (TPC) was determined using total phenolic peaks area using gallic acid 
standard curve. The results are expressed in mg of gallic acid equivalents/L of extract. 
 
Among all extracts, Brooks cherry exhibited the highest phenolic content whereas Sweet 
Heart cherry extract presented the lowest value. This difference between phenolic content 
of cherry extracts was also revealed in Figure 3.5 which was evident for the highest peaks 
intensity of Brooks cherry sample. 
Antiproliferative activity of cherries extracts, using Sweet Heart and Brooks varieties, are 
presented in Figure 3.6.  
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Figure 3.6 : Antiproliferative activity of Brooks and Sweet Heart cherry extracts in HT29 colon cancer 
cell line (incubation time=24 h; results are mean ± SD (n=3)).  
Between the two cherry extracts, Brooks cherry was the most effective in inhibiting HT29 
cells proliferation. The required amount of extract to decrease cancer cell viability was 
extremely low (EC50=0.092 ± 0.014 mg extract/ml). This result suggests that extraction of 
this fruit variety was highly selective to isolate of powerful anticancer agents. The high 
antiproliferative effect of Brooks cherry could be related not only with the presence of 
perillyl alcohol, compound already described to be a powerful anticancer agent, but also 
with the highest phenolic content of this sample (Table 3.3). 
The antiproliferative effect of plum and peach extracts is presented in Figure 3.7. 
 
 
Figure 3.7:  Antiproliferative effect of plum and peach extracts on HT29 cells (incubation time=24 h; 
results are mean ± SD (n=3)) 
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Results showed that dose-response curves of plum and peach residue extracts were similar.  
Between the two samples, peach extract showed lower EC50 value (1.217 ± 0.275 mg 
extract/ml) than plum extract (EC50=2.767 ± 0.666 mg extract/ml). The higher anticancer 
effectiveness of peach sample could be related to the presence of a higher content in 
phenolic compounds (Figure 3.5 (A)). As presented in Table 3.3, this extract exhibited three 
times more total phenolic content than plum extract. As mentioned above, vanillin and 
naringenin were the main compounds identified in peach samples. This compounds were 
already reported to have potent antiproliferative activity and pro-apoptotic effect on HT29 
cancer cell lines, and, therefore, could be the main responsible of the higher 
antiproliferative effect of peach extract [159, 160]. 
In Table 3.4 are summarized the EC50 values obtained for all screened extracts. 
Table 3.4: EC50 values of natural extracts (incubation time=24 h). 
Phytochemical extract EC50 (mg extract/ml) 
Orange peel (1st fraction) 0.488 ± 0.031 
Brooks Cherry 0.092 ± 0.014 
Sweet Heart Cherry  1.608 ± 0.416 
Peach 1.217 ± 0.275 
Plum 2.767 ± 0.666 
 
Among all samples, Brooks cherry and orange peel extracts showed the lowest effective 
dose values, and thus were the most promising natural extracts to be further tested in more 
robust cancer cell models. 
It is important to mention that for all samples, EC50 doses were not cytotoxic in Caco2 cell 
model. 
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3.2 3D model Development 
 
3.2.1 Generation of 3D model of colon cancer  
In recent years, several authors have been developing colon cancer 3D models, including the 
use of HT29 cell line, however, the majority of these models are based on static culture 
systems [161-163]. These cultures present several limitations such as the low spheroid 
numbers generated and the selection of the most aggregative cells, as these are systems 
based on spontaneous cell aggregation. The use of stirred systems for the 3D culture of 
cancer models presents several advantages that might overcome some of the limitations 
associated with static 3D culture systems. With the goal of developing a robust and 
reproducible 3D colon cancer model of HT29 cells, a stirred system was used.  
Spheroids formation and growth was carried out using spinner-vessels Corning® 
Proculture® spinner flasks. This suspension culture vessel with 125 ml capacity is equipped 
with features which ensure optimal stirring with low levels of shear stress and enhanced 
aeration and agitation of spheroid suspension. This system allows easy scale up for larger 
vessel sizes culture systems. The use of this culture system allows the production of a large 
number of homogeneous colon cancer spheroids within the same batch [164].  
The cultures were followed during 12 days and, cell concentration and spheroid size and 
number were monitored along time. The results obtained for the optimized culture 
conditions are presented in Figure 3.8.  
 
 
Figure 3.8: HT29 spheroid culture characterization in stirred culture systems. Monitoring of 
spheroids diameter, concentration and total cell concentration in culture. Data are mean ± SD of four 
independent experiments.  
Average spheroid diameters in suspension culture system were measured based on 
microscope fluorescence images (Figure 3.10), obtaining a diameter distribution histogram 
for each daily time point (Figure 3.9). Along the culture, it is possible to verify a gradual 
increase in cell concentration due to the proliferative character of colon cancer cells.   
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Figure 3.9 : HT29 spheroid size distribution along culture time in stirred culture system. Spheroid 
feret diameter was determined as described in section 3.4.3. Results were mean ± SD of four 
independent experiments. All the means present significant difference with P<0.0001 by one-way 
ANOVA analysis. 
Spheroid culture viability was assessed using a dual staining with FDA and PI. Non-viable 
cell were stained in red and viable in green stain (section 2.3.5). The results obtained by 
fluorescence and bright field microscopy of HT29 spheroids along the culture time are 
presented in Figure 3.10. 
 
 
S
p
h
e
r
o
id
 D
ia
m
e
te
r
 (

m
)
1 2 3 4 5 6 7 9
1
2
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
6 0 0
7 0 0
8 0 0
9 0 0
T im e  (D a y )
42 
 
 
Figure 3.10 : Monitoring of 3D HT29 cultures, along culture time. Phase contrast and fluoresce 
microscopy images. Viable cells were stained with FDA (green) and non-viable cells were stained 
with PI (red). Data is from one representative 3D culture of four experiments (scale bar=300 µm) 
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During culture time it was possible to distinguish three distinct phases: an initial 
aggregation phase, followed by spheroid compaction and a third phase characterized by 
spheroid growth.  
The early stage of culture corresponded to the aggregation step of HT29 cells. Aggregation 
took place in the first 24 hours of culture and it was mainly characterized by maintenance of 
cellular concentration, accompanied by an increase in the spheroid size. The HT29 cell line 
presented a fast aggregative character and 6 hours of inoculation, spheroids could already 
be found in suspension (Figure 3.8). At this point, the culture was composed by a 
heterogeneous population of cells, containing both small cell spheroids as well as floating 
single cells (Figure 3.10). HT29 cells continued to aggregate until 24 h post-inoculation and 
the diameter of the spheroids increased rapidly (average diameter of 200 µm, Figures 3.8 
and 3.9). During this period cellular concentration was maintained (Figure 3.8), suggesting 
that the observed increase in spheroid diameter was due to cell aggregation and aggregates 
fusion. 
Between the 1st and 2nd day, a 2-fold increase in cell concentration was observed, although 
spheroid diameter was kept stable which indicated that spheroid compaction was 
occurring. Moreover, the decrease in spheroid density observed from day 1st day also 
suggests the occurrence of spheroid fusion (Figure 3.8).  
From the 3rd day onwards, spheroid diameter increased, together with an increase in cell 
concentration. In addition, during this period (day 3 onwards), spheroids presented low 
light penetration, evidenced by the darker appearance of spheroids, suggesting a high level 
of compaction of spheroids (Figure 3.10). It was observed that high viability was maintained 
along the process, with cells stained with PI being a small minority, mostly in the first 
culture days during aggregation and compaction (Figure 3.10).  
In sum, after the optimization, the aggregation was achieved and multicellular tumor 
spheroids were obtained with high cellular viability along the culture. The selected method 
for generation of 3D colon cancer model displays several advantages. Comparing to static 
culture systems-based methods to obtain spheroids, this system allowed the achievement of 
compact colon cancer spheroids in a shorter amount of time [128].  Furthermore, the 
utilization of spinner vessels allowed the generation of a high number of spheroids, for 
further characterization and utilization in several assays. In addition, this culture system is 
compatible with live monitoring of the 3D models, with frequent non-destructive sampling 
and assessment of the properties of the spheroids at different stages of progression.  
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3.2.2 Phenotypic characterization 
The 3D cell model generated in this thesis work was phenotypically characterized along the 
culture time by flow cytometry and immunofluorescence microscopy.  
Firstly, cancer stem cells (CSCs) in both, 2D and 3D, cultures were quantified by assessing 
the expression of CD44 using flow cytometry. The study was carried out with HT29 cells 
from tumor spheroids collected at third day of 3D culture, after the aggregation and 
compaction phase. For the analysis of the cell population by flow cytometry, tumor 
spheroids were dissociated into a single cell suspension using enzymatic dissociation, as 
described in section 2.3.5. 
The results presented in Figure 3.11 indicate a highly enriched CD44+ cell population for 
both culture systems. HT29 spheroids at day 3 of 3D culture (Figure 3.11(A)) presented 
97.89 ± 0.80 %, and for 2D monolayer culture (Figure 3.11 (B)) 98.81 ± 0.20 % of CD44+ 
cells. 
 
Figure 3.11: Flow cytometry analysis of CD44 expression in HT29 cells cultured in 2D (A) and 3D 
conditions at day 3 of culture (B). Results from one representative experiment of 3 independent 
assays. 
Quantification of CD44 cell marker suggested a high percentage of CSCs in 2D and 3D 
cultures. CD44 is consistently overexpressed in colorectal cancer and other types of 
carcinomas. This membrane receptor  recognizes chemoatractants and cytokines 
responsible for cell motility and invasion [165]. CSCs are identified by the expression of 
specific cell surface markers which includes CD44, but also CD133 and CD166 on colon 
cancer [166]. Therefore, to confirm the CSC character of these cells, it would be necessary to 
perform additional characterization for some of these markers. CSCs are often involved in 
the growth of colon cancer and can be associated with chemotherapeutic resistance and 
tumor metastasis (section 1.1.3) [167].  This cell population might be the cause of tumor 
itself, as described in section 1.1 or they can arise by a dedifferentiation process, verified 
after EMT, which occurs during metastization  (section 1.1.2) [168]. 
HT29 cells in tumor spheroid were further characterized by assessment of 
epithelial/mesenchymal character at day 3, 7 and 12 of culture by fluorescence microscopy 
in spheroid cryosections, with immunodetection of β-catenin, cytokeratin 18, E-cadherin, 
CD44 and vimentin. F-actin was identified by using the fluorescent molecular probe 
phalloidin (Figure 3.12 and Figure 3.13). 
 
 
C
o
u
n
ts
0 6 0 1 2 0 1 8 0 2 4 0
0
2 0 0
4 0 0
6 0 0
10 .1 10 100 1 000
C D 4 4
+
c e lls
A B
C
o
u
n
ts
0 6 0 1 2 0 1 8 0 2 4 0
0
2 0 0
4 0 0
6 0 0
10 .1 10 100 1 000
C D 4 4
+
c e lls
45 
 
 
 
 
 
2D control Day3 Day7 Day12
E
-c
a
d
h
e
ri
n
β
-c
a
te
n
in
F-
a
ct
in
C
K
 1
8
C
D
4
4
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
D
A
P
I 
F
ig
u
re
 3
.1
2
 :
 C
h
ar
ac
te
ri
za
ti
o
n
 o
f 
H
T
2
9
 3
D
 c
u
lt
u
re
s 
b
y
 i
m
m
u
n
o
fl
u
o
re
sc
en
ce
 m
ic
ro
sc
o
p
y
. D
et
ec
ti
o
n
 o
f 
β
-c
at
en
in
, E
-c
ad
h
er
in
, 
F
-a
ct
in
, c
y
to
k
er
at
in
 1
8
 a
n
d
 C
D
4
4
 a
lo
n
g 
sp
h
er
o
id
s 
gr
o
w
th
 p
ro
ce
ss
 (
d
ay
 3
, 7
 a
n
d
 1
2
).
 D
A
P
I 
w
as
 u
se
d
 t
o
 s
ta
in
 n
u
cl
ei
. 
 
46 
 
The results revealed obvious differences in spheroids along culture time. At an early stage of 
culture (day 3), spheroids were small and homogeneous. In contrast, larger spheroids (day 
7 and 12) exhibited a heterogeneous structure with high compacted cells in spheroid 
periphery and low compacted cells in spheroid center (Figure 3.12).  
 
Figure 3.13: Characterization of HT29 spheroids by immunofluorescence microscopy. High 
magnification images of β-catenin and F-actin detection. Nuclei were labeled with DAPI. White arrow 
indicates non-membranar β-catenin location. 
Results concerning epithelial markers (Figure 3.12 and Figure 3.13) indicated that up to day 
7, the spheroid cellular population exhibited epithelial characteristics, positive for E-
cadherin and where β-catenin was mostly found in the membrane. Nonetheless, at day 12 of 
culture, HT29 cells located in the central area of spheroids lost the expression of E-cadherin, 
while β-catenin was detected in the cytosol (Figure 3.13, white arrow).  
F-actin was also detected in tumor spheroids, under the form of an actin ring in the 
membrane area, except in the center of spheroids with 12 days of culture, in which it 
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presented a cytoplasmic punctate pattern (Figure 3.13). This pattern may indicate apoptotic 
activity, as f-actin cleavage has been described associated with this type of cell death [169]. 
Concerning CK18 expression, differences were observed between day 3 and day 7/12 of 
culture (Figure 3.12).  Indeed, at day 3 there was strong detection distributed through the 
whole tumor spheroid, in accordance with the epithelial phenotype previously described for 
of HT29 cells [170]. However, in spheroids collected at day 7 and day 12 of culture CK18 
was detected only in the central area of the spheroids. These larger spheroids also 
presented a positive staining for CD44, exclusively in the peripheral region.  
The mesenchymal phenotype of HT29 cell spheroids were evaluated by 
immunofluorescence microscopy of vimentin and the results are presented in Figure 3.14. 
 
Figure 3.14 : Characterization of 3D cultures by immunofluorescence microscopy. Identification of 
vimentin along culture time (day 3, 7 and 12). In the right side are presented the respective 
magnified images. DAPI was used to stain nuclei. White arrows indicate vimentin punctate pattern. 
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Results showed that HT29 spheroids cells at day 3 of culture did not expressed vimentin, in 
contrast with spheroids collected at day 7 and 12 which presented a punctate pattern in the 
central area (Figure 3.14 (white arrows)). This labeling pattern suggested that vimentin was 
in a cleaved form due to proteolysis. This is a common sign of apoptotic activity, in which 
vimentin is cleaved by active caspases leading to cell apoptosis [171]. 
Therefore, to evaluate apoptosis in the tumor spheroids, a form of CK18 cleaved by caspase-
3 was detected using a specific antibody (M30 antibody).  Figure 3.15 shows the M30 
staining of apoptotic cells. 
 
 
Figure 3.15 : Characterization of 3D cultures by immunofluorescence microscopy. Detection of early 
apoptotic cells using M30cytodeath marker, along culture time (day 3, 7 and 12). DAPI was used to 
stain nuclei 
The results suggested the existence of relevant apoptotic activity in the core of spheroids at 
day 12 of culture. As CK18 was not detected in the peripheral layer of spheroids at day 7 
and 12 of culture, it was not possible to conclude about apoptotic activity in the spheroids 
periphery. Nonetheless, at day 12 of culture, spheroids exhibited about 800 µm of diameter, 
which most probably limited mass transfer of nutrients and oxygen, even in stirred culture 
systems. Besides, the accumulation of toxic metabolites in the core area might also 
contribute to the induction of apoptosis [121]. 
Detection of relevant cell markers expression is summarized on Table 3.5, as well as their 
respective location in the colon cancer spheroid. 
 
 
 
DAPI 
M30 
 
DAPI 
M30 
 
DAPI 
M30 
 
DAPI 
M30 
 
49 
 
Table 3.5: Cell markers localization along the culture time. 
 
Cell marker  localization on spheroid  
(core/periphery) 
Culture E-cadherin Vimentin CK 18 CD44 
2D + + + + 
3
D
 Day 3 +/+ -/- +/+ +/+ 
Day 7 +/+ -/- +/- -/+ 
Day 12 -/+ +/- +/- -/+ 
 
In general, it was observed relevant phenotypic alterations mainly between spheroids 
collected at day 3 of culture and spheroids collected at day 7 and 12.  
A consistently expression of CD44 and vimentin by HT29 cells, in 2D cultures, can be related 
with a prior EMT, which is associated to the generation of cancer cells with a stem cell 
character and phenotype [27]. The expression of CD44 can also be due to the tumor cellular 
origin, as colon tumors originated in crypt stem cells usually present  stem cell markers in 
the primary tumor [6]. 
In cell spheroids CD44 detection was limited to the outer layer of the tumor spheroid at 
later culture stages. This result, combined with the loss of detection of the epithelial marker 
CK18 suggests  the occurrence of a dedifferentiation process, and it could be correlated with 
in vivo tumors which exhibit a dedifferentiated invasive front [172]. 
E-cadherin expression was frequently detected in spheroid areas of higher cellular 
compaction, due to their crucial role in maintenance of cell-cell contacts. Spheroids at day 
12 of culture revealed a greater area of low compaction in the center of the spheroid, which 
lack the cell-cell contacts. Herein, E-cadherin expression was not detected which may be 
explained by the loss of cell-cell contacts [173].  
E-cadherin and cytokeratin 18 (CK18) are generally found in adenocarcinomas which 
present an epithelial phenotype [170, 173]. Thus, tumor cells with epithelial characteristics 
show a positive staining for E-cadherin, a trans-membrane adhesion receptor required to 
form and maintain adherens junctions (AJs) and for CK18 which is a cytoskeleton protein 
with an important role in maintaining cell shape and internal organization [170]. The loss of 
E-cadherin and other epithelial characteristic proteins, such as cytokeratins, can be 
associated with the transition to a mesenchymal character or with the loss of cell-cell 
contacts in the core of the spheroid. Usually, when cancer cells acquires an invasive 
phenotype, they lose the adhesion with surrounding cells and decrease cytoskeleton 
proteins expression [170].  
Alterations in F-actin (filamentous actin, another structural protein,) which displays a 
crucial role in the maintenance of epithelial cells polarity through the actin bundles, can also 
be related with EMT process. These bundles are lost when colonic cancer cells become 
unpolarized and acquire motility [174, 175]. In this case, it is possible to identify actin 
filaments in cell cytoskeleton which can be involved in cell movement [176]. However, 
immunofluorescence microscopy of cells stained with f-actin only revealed some evidences 
of apoptotic activity at day 12, due probably to hypoxic conditions.  
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As well as F-actin, β-catenin cellular location can also change when EMT occurs. β-catenin 
can be identified in cellular membrane by immunofluorescence microscopy if cancer cells 
which present an epithelial phenotype and express E-cadherin (section 1.1.2). When the cell 
loses the E-cadherin expression, β-catenin is translocated into de nucleus or it may be also 
found diffusely distributed in the cytoplasm  [25].  
Besides the loss of epithelial characteristics, it is usual to find mesenchymal characteristic 
proteins, such as vimentin, in cells that undergo EMT.  Vimentin is a type III intermediate 
filament which plays an important role in supporting the position of the organelles in 
cytosol and offers cell flexibility. Often, vimentin is expressed in epithelial invasive late 
carcinomas [177]. The expression of vimentin was identified in HT29 cells cultured in 2D 
and it was lost when cells were cultured in 3D spheroids. However, at day 12 of culture, it 
was detected a punctate pattern of vimentin in the core of spheroids, in association with the 
loss of membrane β-catenin. These results suggest that these cells probably undergone 
EMT. The evidence of EMT in spheroids core cells might be linked with the hypothesis that 
this area presents hypoxic conditions. Higgins et al. have demonstrated that EMT may be 
induced by hypoxia in renal epithelial cells [178]. In addition, to provide conclusions about 
the occurrence of EMT, further studies have to be performed using additional cell markers. 
The characterization of the obtained 3D model along culture time allowed to establish a 
relation with some of the features observed in tumor progression in vivo. Spheroids 
collected at day 7 or 12 presented a higher similarly degree with malignant tumors, with 
less differentiated cells located in the cancer’s outer area, while presenting an 
apoptotic/necrotic center due to diffusion limitations. These older spheroid microregions 
could simulate micrometastases or intervascular microregions of larger tumors [144]. 
Hence, it is possible to mimic multiple cancer stages according to the type of study. 
Indeed, 3D model characterization allows concluding about the type of cancer model used in 
the in vitro anticancer assays, as well as establishing a relation between the characteristics 
of this in vitro model and in vivo tumor stage. 
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3.3 Evaluation of anticancer potential of natural extracts using 3D cell 
models 
 
In the final part of this work the most promising natural extracts selected from 2D 
antiproliferative assays (section 3.1) were evaluated for their anticancer potential using the 
3D cell model developed previously (section 3.2). The biological activity of orange peel and 
Brooks cherry extracts was assessed by analyzing i) antiproliferative effect; ii) cell cycle 
arrest and iii) induction of apoptosis. 
 
3.3.1 Antiproliferative activity 
Antiproliferative effect of Brooks cherry and orange peel extracts was evaluated using HT29 
spheroids with different diameters, approximately 300, 400 and 500 µm. The dose-response 
curves obtained for all samples after 24 hours of incubation are presented in Figure 3.16. 
 
Figure 3.16: Dose-response curves of orange peel (A) and Brooks cherry (B) on HT29 cell spheroids 
with different sizes (incubation time=24; results are mean ± SD (n=6)). 
In addition, perillyl alcohol, the main bioactive compound identified in cherry extracts, was 
also tested aiming at evaluating the antiproliferative effect of a single compound in this 3D 
cell model (Figure 3.17). 
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Figure 3.17: Dose-response curves of perillyl alcohol on HT29 cell spheroids with different sizes 
(incubation time=24; results are mean ± SD (n=6)). 
Results showed that the antiproliferative effect of natural extracts was dependent of HT29 
spheroid size. This result could be related with the poor diffusion of the main 
phytochemicals presented in both extract samples, through HT29 spheroid. This effect was 
not observed for perillyl alcohol, probably due to the low molecular size and the high 
lipophilic character (see appendix C)  that can provides a high diffusion capacity and 
efficient mass-transfer into cancer cells spheroids [179].  
In Table 3.6 are compared the EC50 values of natural extracts and perillyl alcohol obtained 
using 2D and 3D models of colon cancer cells.  
 
Table 3.6: EC50 values of natural extracts and perillyl alcohol determined using 2D and 3D cell 
models (incubation time= 24 h). 
 EC50 (mg extract/ml)  
 Orange Cherry Brooks POH (mg/ml) EC50 
2D model 0.488 ± 0.031 0.092 ± 0.014 0.146 ± 0.037 
3
D
 m
o
d
el
 300 µm 0.538 ± 0.049 0.105 ± 0.007 0.152 ± 0.056 
400 µm 0.709 ± 0.291 0.161 ± 0.022 0.157 ± 0.021 
500 µm 1.308 ± 0.153 0.224 ± 0.133 0.172 ± 0.030 
 
Overall, results showed that when tested in 3D model both natural extracts decreased their 
antiproliferative effect (increase of EC50 values). However, the effect was less evident for 
smaller spheroids (300 µm). As described previously, phenotypical characterization of 
smaller spheroids showed multiple resemblances with monolayer culture cells (section 
3.2.2).  In addition, the spheroids with 300 µm of diameter are less compacted than 400 and 
500 µm cell spheroids and thus, the diffusion of the main bioactive molecules were probably 
not affected in 300 µm spheroids. Regarding tumor spheroids with 500 µm of diameter, the 
EC50 values of both extracts increased more than two times in relation to 300 µm 
spheroids. Furthermore, 500 µm spheroids displayed characteristics observed in in vivo 
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carcinoma, such as the hypoxic/apoptotic core and less differentiated cells in the 
surrounding area, which confers chemotherapeutic resistance [140]. These characteristics, 
combined with mass transport limitations as observed in this size of spheroid, can be the 
cause of greater resistance to the extracts treatment [140]. 
By contrast, the EC50 values for perillyl alcohol obtained in 2D and 3D cell based assays 
were similar, reinforcing the high permeability and diffusion properties of this compound 
through HT29 cell spheroids. 
Aiming at evaluating if the incubation time improved the antiproliferative response of 
natural extracts, HT29 cell spheroids were incubated with the tested extracts for 72 hours.  
In Figure 3.18 is presented the EC50 values determined for incubations with natural 
extracts for 72 hours. Results were compared with EC50 data obtained for 24 hours of 
incubation. 
 
Figure 3.18: EC50 values of antiproliferative effect on HT29 tumor spheroids, after 24 and 72 hours 
of incubation with orange peel (A) and cherry Brooks (B) extract. Data are mean ± SD of nonlinear 
curve fitting (n=6). 
In general, the antiproliferative effect of both extracts was improved after 72 hours of 
incubation. A decrease of about 2 times on EC50 values recorded at 72 hours was observed 
in relation to effective doses achieved at 24 hours, for all cell spheroids. These findings 
suggest that the increase of time exposure leads to a decrease of the therapeutic resistance 
of tumor spheroids. The diffusion of the main bioactive compounds was probably enhanced 
by this longer treatment. 
The decrease of chemotherapeutic sensibility between 2D and 3D tumor cultures was 
already verified in prior studies. In particular, for colon cancer tumor spheroids, the 
chemoresistance was studied for the treatment with several drugs including, 5-FU, 
oxaliplatin, irinotecan and melphalan. The differences in drug resistance between older 
spheroids and 2D/early spheroids have been highly associated with the presence of hypoxic 
regions and with an increased expression of stem cell marker CD44 [140, 163].  Hence, 
further studies have to be performed in order to assess the influence of CD44 expression in 
the resistance to extracts therapy. 
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3.3.2 Cell cycle analysis 
Chemotherapeutic drugs may exert their effects by stopping cell replication. This replicative 
process, cell cycle, comprises four stages: G1 (cell growth phase), S (DNA synthesis), G2 
(pre-mitotic phase) and M (cell division by mitosis). 
In order to determine whether natural extracts induced a cell cycle arrest of HT29 tumor 
spheroids, a flow cytometric analysis of cell cycle was performed. Colon cancer spheroids 
with 500 µm of diameter were selected for this study because at this stage they presented a 
central necrotic/apoptotic core and a compact outer ring, phenotypic characteristics of a 
primary tumor in with intravascular microregions in vivo (section 3.2.2). 
HT29 spheroids were incubated for 24 hours with natural extracts and perillyl alcohol. For 
all samples, the concentration tested was the one that provided a decrease of 30% in cell 
proliferation (section 3.3.1). The results are presented in Figure 3.19. 
 
Figure 3.19 : Cell cycle distribution on HT29 cells in the tumor spheroid (diameter=500 µm) after 
incubation with natural extracts (A) and perillyl alcohol (B) (incubation time=24 h). Results are mean 
± SD of four independent experiments. The significant differences are expressed in asterisks (* P<0.5 
and**** P<0.0001) by two-way ANOVA analysis. 
 
The results showed that natural extracts induced cell cycle arrest in different cell cycle 
checkpoints (Figure 3.19(A)). Particularly, cherry Brooks extract induced cell cycle arrest in 
G1 phase. This effect is in accordance with previous observations using HT29 monolayer 
culture (2D) and with other cherry extracts presenting similar phytochemical composition 
[90]. It could be related with the presence of perillyl alcohol demonstrated in previous 
studies [53], that displayed similar response in HT29 cell spheroids (Figure 3.19 (B)). Also, 
it is in accordance with previous reports that demonstrated that perillyl alcohol affects the 
expression of key regulatory proteins of cell cycle (cyclin D1, cyclin E, cdk2 and cdk4) which 
are involved in G1-S phase transition [98]. 
For orange peel extract, an induction of cell cycle arrest in the G2/M phase was observed. As 
described in section 3.1.2, PMFs are the main bioactive compounds present in orange peel 
extract. These compounds were already reported to induce cell cycle arrest in different cell 
cycle checkpoints of colon cancer cell lines [73, 83]. In particular, an induction of the G2/M 
phase was verified by sinensetin in gastric adenocarcinoma cells [83]. Thus, these 
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compounds could be one of the main contributors for the bioactive effect of orange extract. 
The other compounds, namely tangeretin and nobiletin, are also reported to induce cell 
cycle arrest in HT29 but in different cell cycle checkpoints, S and G1 respectively, in human 
colon adenocarcinoma [73]. These findings suggest that tangeretin and nobiletin may have a 
low influence on cell cycle regulation of orange extract in HT29 spheroids. This result could 
be justified with the chemical structure of this compounds that may compromised their 
diffusion and mass transfer through spheroid. Further studies should be performed in this 
3D cell model with these phytochemical compounds, alone and in combination, in order to 
identify the main bioactive molecules of orange natural extracts. 
 
 
3.3.3 Apoptosis induction 
The effect of phytochemical extracts on induction of apoptosis in HT29 tumor spheroids 
was assessed through the evaluation of caspase-3 activity, which are proteases that play an 
essential role in the apoptotic process [180]. For both extracts, assays were performed with 
different spheroid sizes using the EC50 value previously obtained for 300 µm spheroids. In 
Figure 3.20 are presented the results obtained by fluorescence microscopy of the cell 
spheroids. 
 
Figure 3.20:  Evaluation of apoptotic activity on HT29 cells in tumor spheroids incubated with 
natural extracts by fluorescence microscopy (incubation time=24 h). Detection of capase-3 (green) 
and mitochondrial activity (red) for spheroids with 300, 400 and 500 µm of diameter. 
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The results showed that natural extracts induced apoptosis in HT29 spheroids. It is 
important to note that this effect was more pronounced in smaller spheroids (300 µm), 
which is in accordance with the antiproliferative results. However, for spheroids with 400 
and 500 µm of diameter, it was suggested that the apoptotic effect was more pronounced in 
the surface cells, in contrast to core cells which seem to be less affected. As discussed 
previously, the lowest anticancer effect observed for higher HT29 spheroid sizes could be 
related with mass transfer limitations of the main bioactive compounds of the extracts.  
In fact, images obtained with confocal microscope of HT29 spheroids incubated with orange 
peel extract revealed that apoptotic effect was more pronounced in cells located at the 
spheroid surface (Figure 3.21). 
 
Figure 3.21: Evaluation of apoptotic activity on HT29 cells in tumor spheroids incubated with orange 
peel extract by fluorescence confocal microscopy (incubation time=24 h). Detection of capase-3 
(green) and mitochondrial activity (red) for spheroids with 300, 400 and 500 µm of diameter. 
After 24 hours of orange peel extract treatment, spheroids presented a clear increase in 
apoptotic activity. In particular, for spheroids with 300 µm of diameter, it were detected a 
large number of apoptotic cells, suggesting that the majority of spheroids cells undergo 
apoptosis. These results reinforce the evidences of sinensetin contribution for the 
anticancer effect of orange peel extract. For this PMF the apoptotic effect was reported in 
human gastric adenocarcinoma and was associated with the up-regulation of proteins 
involved in the induction apoptosis of tumor cells [83]. The other main compounds, namely 
tangeretin and nobelitin, were reported to exert a cytostatic effect in colon cancer cell line 
HT29 with no apoptotic effect [73]. The induction of cell cycle arrest by orange peel extract 
has already been associated with sinensetin (section 3.3.2) activity and both results are 
complementary. 
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It is already reported the apoptotic effect of perillyl alcohol, which could be correlated with 
the high apoptotic effect observed after 24 hours of treatment with Brooks cherry extract. 
In lung adenocarcinoma, perillyl alcohol shows to increase the activity of caspase-3, as well 
as to increase the expression of other regulatory proteins related with the apoptotic process 
[181]. 
Furthermore, it is important to note that control spheroids, collected at day 7 of culture, 
revealed a diffuse green fluorescent staining which appear to be located in the core of the 
spheroid. These results emphasize the evidence that cells undergo apoptosis in the core of 
the spheroid due to their larger diameter of the spheroids (section 3.2.2). However, the 
detection of this apoptotic region using this capase-3 cellular marker has to be further 
investigated in order to provide specific conclusions. Additional apoptosis assays, using 
spheroids cryosections, would be carried out with and without extracts exposure. 
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4 Conclusion 
 
In the present study, natural extracts obtained by clean extraction methodologies from fruit 
residues were investigated for their anticancer potential aiming at identifying promising 
bioactive molecules for the development of natural chemotherapeutic agents towards colon 
cancer.  
Among 14 natural extracts screened in a 2D model of HT29 colorectal cancer cells, orange 
peel and Brooks cherry extracts distinguished for presenting higher antiproliferative effect. 
These extracts were produced by high pressure technology that revealed to be an efficient 
process to extract and isolate potent bioactive molecules namely perillyl alcohol and 
polymethoxylated flavones from sweet cherries and orange peels, respectively. The 
potential anticancer effect of these natural extracts were also validated in a 3D model of 
HT29 cell spheroids, which showed similarities with in vivo tumor, including similar 
phenotypes and resistance to chemotherapy agents. Orange peel and cherry extracts 
inhibited colon cancer cells proliferation and promoted apoptosis in HT29 spheroids, and 
this effect was dependent with the tumor spheroid size. Moreover, natural extracts induced 
cell cycle arrest in different cell cycle checkpoints - cherry extract induced cell cycle arrest 
at G1 phase while orange peel extract induced at G2/M phase- which was correlated with 
their phytochemical composition.   
Overall, the use of colorectal cancer cell spheroids constitutes an improved and feasible 
alternative to the classic 2D cellular model to evaluate and understand the 
chemotherapeutic potential of bioactive molecules and phytochemical-rich extracts towards 
colon cancer. Future studies should be performed in order to establish relationship between 
natural extracts activity and cellular phenotypical alterations in this 3D cancer cell model. 
Moreover, a better identification of the main bioactive compounds as well as their structure 
is required to further understand the chemotherapeutic effect and mechanisms of natural 
compounds.  
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6 Appendix 
 
Appendix A – Cellular viability assays 
 CellTiter 96® Aqueous One Cell Proliferation Assay 
The CellTiter 96® Aqueous One Cell Proliferation Assay is a colorimetric method used in 
proliferation or cytotoxicity assays for determining the number of viable cells. This assay 
contains MTS tetrazolium compound (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt), which is bioreduced 
by cells into a colored formazan product soluble in culture medium [182]. 
Methodology: 
It was added 100 µl of MTS solution (16.6% MTS in RPMI culture medium with 0.5% of FBS) 
was added to each well, after medium removal. Cells were incubated with MTS solution for 
4 hours at 37 0C in a humidified, 5% CO2 atmosphere and the absorbance was read in a 96-
well plate reader at 490 nm. 
 
 PrestoBlue® Cell Viability Reagent 
PrestoBlue® Cell Viability Reagent is a reagent for rapidly evaluating the viability and 
proliferation of a wide range of cell types. This is a nonfluorescent resazurin-based solution 
which is quickly reduced by metabolic active cells giving a quantitative measure of cell 
proliferation and viability. When it is reduced by viable cells, the PrestoBlue becomes highly 
fluorescent. Using this cell viability method, the assayed cells can be recovered for further 
culturing or use in a subsequent assay [183]. 
Methodology: 
After removed the culture medium, it was added 100 µl of PrestoBlue® solution (10% of 
PrestoBlue® reagent in RPMI culture medium with 0.5% of FBS) to each well. Cells were 
incubated at 37 0C in a humidified, 5% CO2 atmosphere for 2 hours. Finally, the fluorescence 
was measured in a 96-well plate reader at 580 nm for excitation and 595 nm for emission 
detection. 
In Figure 6.1 are presented the standard curves of two viability methods tested in HT29 
spheroids with different sizes and seeded at different concentrations. 
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Figure 6.1: (A) Standard curves for PrestoBlue® regent (300 µm – r2=0.9315; 400 µm – r2=0.9767; 
500 µm – r2=0.9845) and for (B) CellTiter 96 Aqueous One Cell Proliferation Assay (300 µm – 
r2=0.9930; 400 µm – r2=0.9426; 500 µm – r2=0.9754) using different HT29 spheroid number per 
well. Different spheroids sizes were used. 
PrestoBlue® was the selected method for the evaluation of cell viability in the 3D model, 
since the CellTiter 96® method lacks linearity for spheroids of greater diameter. Thus, 
PrestoBlue appeared to be the most linear method to be used in further assays. 
 
 
Appendix B – TLC analysis 
 
Figure 6.2: TLC analysis of natural extracts obtained by high pressure extraction to reveal terpenes. 
Legend: 1- perillyl alcohol standard; 2- Linalool standard; 3- Brooks cherry; 4- Sweet Hearth cherry; 
5- plum; 6- peach; 7- Orange peel. 
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Appendix C – Structure of compounds 
 
Table 6.1: Structure of the main compounds present in natural extracts of orange peel and cherry  
Sinensetin 
 
Nobiletin 
 
Tangeretin 
 
Perillyl alcohol 
 
 
  
 
